OA20326A - Herbicidal compositions. - Google Patents

Herbicidal compositions. Download PDF

Info

Publication number
OA20326A
OA20326A OA1202100363 OA20326A OA 20326 A OA20326 A OA 20326A OA 1202100363 OA1202100363 OA 1202100363 OA 20326 A OA20326 A OA 20326A
Authority
OA
OAPI
Prior art keywords
formula
herbicide
compound
composition
component
Prior art date
Application number
OA1202100363
Inventor
James Nicholas Scutt
Nigel James Willetts
Ravindra SONAWANE
Mangala Phadte
Sandeep Reddy KANDUKURI
Sarah Armstrong
Andrea MCGRANAGHAN
Sean NG
Gavin John Hall
Julia FELLMANN
Raymond Joseph WUERFFEL
Sian MOORHOUSE
Niall Rae THOMSON
Original Assignee
Syngenta Crop Protection Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Crop Protection Ag filed Critical Syngenta Crop Protection Ag
Publication of OA20326A publication Critical patent/OA20326A/en

Links

Abstract

The present invention relates to novel herbicidal combinations and their use in controlling plants or inhibiting plant growth. In particular, herbicidal combinations of the invention comprise at least one pyridazine derivative of Formula (I), in combination with at least one futher herbicide that is a non-selective herbicide, a herbicide that acts through the inhibition of protoporphoryinogen oxidase, or a herbicide that inhibits photosystem II in photosynthesis.

Description

HERBICIDAL COMPOSITIONS
The présent invention relates to novel herbicidal combinations and their use in controlling plants or inhibiting plant growth. In particular, herbicidal combinations ofthe invention comprise at least one pyridazine dérivative as defined herein, in combination with at least one further herbicide that is a non5 sélective herbicide, a herbicide that acts through the inhibition of protoporphoryinogen oxidase, or a herbicide that inhibits photosystem II in photosynthesis.
Herbicidal pyridazine dérivatives are described in co-pending PCT application PCT/EP2018/072280.
The object of the présent invention is to provide herbicidal mixtures which are highly effective 10 against various weed species (particularly at low dose), and is based on the finding that pyridazine compounds of Formula (I) as defined herein, in combination with the partner herbicides described herein, are particularly efficacious at mediating such weed control.
Thus in a first aspect ofthe invention, there is provided a composition comprising as component (A) a compound of Formula (I), or an agrochemically acceptable sait or a zwitterionic species thereof,
wherein:
A is 6-membered heteroaryl selected from the group consisting of:
A-V A-VI A-VII wherein the jagged line defines the point of attachment to the remaining part of a compound of Formula 20 (I), p is 0, 1 or 2 and each R8 is independently selected from the group consisting of NH2, methyl and methoxy;
R1 and R2 are each independently hydrogen or methyl; Q is (CR1aR2b)m; m is 0, 1, or 2; each R1a and R2b are independently selected from the group consisting of hydrogen, hydroxy, methyl, and NH2; Z is S(O)2OR10, -C(O)OR10, -C(O)NHS(O)2R12 and -C(O)NHCN; R10 is hydrogen, methyl, benzyl or phenyl; 25 and R12 is methyl, -NH2, -N(CH3)2, or -NHCH3;
and as component (B), at least one herbicide, or sait thereof, selected from the group consisting of:
B1 a non-selective herbicide selected from the group consisting of glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquatand diquat;
B2 a herbicide that acts through the inhibition of protoporphoryinogen oxidase; and
B3 a herbicide that inhibits photosystem II in photosynthesis.
In a second aspect, the invention provides the use of a composition of the invention as a herbicide.
In a third aspect, the invention provides methods of (i) inhibiting plant growth, and (il) controlling plants, said methods comprising applying to the plants orto the locus thereof, a herbicidally effective amount of a composition ofthe invention.
In a fourth aspect, the invention provides methods of (i) inhibiting plant growth, and (ii) controlling plants, said methods comprising applying to the plants orto the locus thereof: (A): a compound of Formula (I) as defined herein, and (B) a herbicide as defined in B1, B2 or B3 as defined herein.
In a fifth aspect, the invention provides a method of selectively controlling grasses and/or weeds 15 in crops of useful plants which comprises applying to the useful plants or locus thereof or to the area of cultivation a herbicidally effective amount of a composition ofthe invention.
When active ingrédients are combined, the activity to be expected (E) for any given active ingrédient combination obeys the so-called Colby Formula and can be calculated as follows (Colby, S.R., Calculating synergistic and antagonistic responses of herbicide combination, Weeds, Vol. 15, 20 pages 20-22; 1967):
ppm = milligrams of active ingrédient (a.i.) per liter
X = % action by first active ingrédient using p ppm ofthe active ingrédient
Y = % action by second active ingrédient sing q ppm ofthe active ingrédient.
According to Colby, the expected action of active ingrédients A +B using p + q ppm of active 25 ingrédient is represented by the following formula:
E=X+YX Y
100
If the action actually observed (O) is greaterthan the expected action E then the action ofthe combination is super-additive, i.e. there is a synergistic effect. In mathematical terms, synergism corresponds to a positive value for the différence of (O-E). In the case of purely complementary addition of activities (expected activity), said différence (O-E) is zéro. A négative value of said différence (O-E) signais a loss of activity compared to the expected activity.
Compounds of Formula (I) and compounds within groups B1, B2 and B3 are ail effective herbicidal compounds, as shown herein with respect to compounds of Formula (I) and as well known in the art for the compounds glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquat and diquat 35 as well as herbicides that act through the inhibition of protoporphoryinogen oxidase; and herbicides that inhibit photosystem II in photosynthesis.
Accordingly, the combination of the présent invention takes advantage of any additive herbicidal activity, and certain embodiments may even exhibit a synergistic effect. This occurs wheneverthe action of an active ingrédient combination is greaterthan the sum ofthe actions ofthe individual components.
Combinations ofthe invention may also provide for an extended spectrum of activity in comparison to that obtained by each individual component, and/or permit the use of lower rates of the individual components when used in combination to that when used alone, in order to médiate effective herbicidal activity.
In addition, it is also possible that the composition ofthe invention may show increased crop tolérance, when compared with the effect ofthe compound A alone. This occurs when the action of an active ingrédient combination is less damaging to a useful crop than the action of one ofthe active ingrédients alone.
As stated above, compositions ofthe invention comprise as component (A) a compound of Formula (I) as defined herein. More details with respect to compounds of Formula (I) are provided below.
The presence of one or more possible asymmetric carbon atoms in a compound of Formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also atropisomers may occur as a resuit of restricted rotation about a single bond. Formula (I) is intended to include ail those possible isomeric forms and mixtures thereof. The présent invention includes ail those possible isomeric forms and mixtures thereof for a compound of Formula (I). Likewise, Formula (I) is intended to include ail possible tautomers (including lactam-lactim tautomerism and ketoenol tautomerism) where présent. The présent invention includes ail possible tautomeric forms for a compound of Formula (I). Similarly, where there are di-substituted alkenes, these may be présent in E or Z form or as mixtures of both in any proportion. The présent invention includes ail these possible isomeric forms and mixtures thereof for a compound of Formula (I).
The compounds of Formula (I) will typically be provided in the form of an agronomically acceptable sait, a zwitterion or an agronomically acceptable sait of a zwitterion. This invention covers ail such agronomically acceptable salts, zwitterions and mixtures thereof in ail proportions.
For example a compound of Formula (I) wherein Z comprises an acidic proton, may exist as a zwitterion, a compound of Formula (l-l), or as an agronomically acceptable sait, a compound of Formula (l-ll) as shown below:
(l-D
wherein, Y represents an agronomically acceptable anion and j and k represent integers that may be selected from 1,2 or 3, dépendent upon the charge ofthe respective amon Y.
A compound of Formula (I) may also exist as an agronomically acceptable sait of a zwitterion, a compound of Formula (l-lll) as shown below:
wherein, Y represents an agronomically acceptable anion, M represents an agronomically acceptable cation (in addition to the pyridazinium cation) and the integers j, k and q may be selected from 1,2 or 3, dépendent upon the charge ofthe respective anion Y and respective cation M.
Thus where a compound of Formula (I) is drawn in protonated form herein, the skilled person would appreciate that it could equally be represented in unprotonated or sait form with one or more relevant counter ions.
In one embodiment ofthe invention there is provided a compound of Formula (l-ll) wherein k is 1 or 2, j is 1 and Y is selected from the group consisting of halogen, trifluoroacetate and pentafluoropropionate. In this embodiment a nitrogen atom in ring A may be protonated or a nitrogen atom comprised in Q may be protonated (for example see compound 1.030 or 1.035 in table A). Preferably, in a compound of Formula (l-ll), k is 1 or 2, j is 1 and Y is chloride, wherein a nitrogen atom in ring A is protonated.
Suitable agronomically acceptable salts for component (A), i.e. a compound of Formula (l-ll) or (l-lll), as employed in the présent invention, and represented by an anion Y, include but are not limited chloride, bromide, iodide, fluoride, 2-naphthalenesulfonate, acetate, adipate, methoxide, ethoxide, propoxide, butoxide, aspartate, benzenesulfonate, benzoate, bicarbonate, bisulfate, bitartrate, butylsulfate, butylsulfonate, butyrate, camphorate, camsylate, caprate, caproate, caprylate, carbonate, citrate, diphosphate, edetate, edisylate, enanthate, ethanedisulfonate, ethanesulfonate, ethylsulfate, formate, fumarate, gluceptate, gluconate, glucoronate, glutamate, glycérophosphate, heptadecanoate, hexadecanoate, hydrogen sulfate, hydroxide, hydroxynaphthoate, isethionate, lactate, lactobionate, laurate, malate, maleate, mandelate, mesylate, methanedisulfonate, methylsulfate, mucate, myristate, napsylate, nitrate, nonadecanoate, octadecanoate, oxalate, pelargonate, pentadecanoate, pentafluoropropionate, perchlorate, phosphate, propionate, propylsulfate, propylsulfonate, succinate, sulfate, tartrate, tosylate, tridecylate, triflate, trifluoroacetate, undecylinate and valerate.
Suitable cations represented by M in a compound of Formula (l-lll), include, but are not limited to, metals, conjugate acids of amines and organic cations. Examples of suitable metals include aluminium, calcium, césium, copper, lithium, magnésium, manganèse, potassium, sodium, iron and zinc. Examples of suitable amines include allylamine, ammonia, amylamine, arginine, benethamine, benzathine, butenyl-2-amine, butylamine, butylethanolamine, cyclohexylamine, decylamine, diamylamine, dibutylamine, diethanolamine, diethylamine, diethylenetriamine, diheptylamine, dihexylamine, diisoamylamine, diisopropylamine, dimethylamine, dioctylamine, dipropanolamine, dipropargylamine, dipropylamine, dodecylamine, ethanolamine, ethylamine, ethylbutylamine, ethylenediamine, ethylheptylamine, ethyloctylamine, ethylpropanolamine, heptadecylamine, heptylamine, hexadecylamine, hexenyl-2-amine, hexylamine, hexylheptylamine, hexyloctylamine, histidine, indoline, isoamylamine, isobutanolamine, isobutylamine, isopropanolamine, isopropylamine, 5 lysine, meglumine, methoxyethylamine, methylamine, methylbutylamine, methylethylamine, methylhexylamine, methylisopropylamine, methylnonylamine, methyloctadecylamine, methylpentadecylamine, morpholine, Ν,Ν-diethylethanolamine, N-methylpiperazine, nonylamine, octadecylamine, octylamine, oleylamine, pentadecylamine, pentenyl-2-amine, phenoxyethylamine, picoline, piperazine, piperidine, propanolamine, propylamine, propylenediamine, pyridine, pyrrolidine, 10 sec-butylamine, stearylamine, tallowamine, tetradecylamine, tributylamine, tridecylamine, trimethylamine, triheptylamine, trihexylamine, triisobutylamine, triisodecylamine, triisopropylamine, trimethylamine, tripentylamine, tripropylamine, tris(hydroxymethyl)aminomethane, and undecylamine. Examples of suitable organic cations include benzyltributylammonium, benzyltrimethylammonium, benzyltriphenylphosphonium, choline, tetrabutylammonium, tetrabutylphosphonium, 15 tetraethylammonium, tetraethylphosphonium, tétraméthylammonium, tetramethylphosphonium, tetrapropylammonium, tetrapropylphosphonium, tributylsulfonium, tributylsulfoxonium, triethylsulfonium, triethylsulfoxonium, trimethylsulfonium, trimethylsulfoxonium, tripropylsulfonium and tripropylsulfoxonium.
Preferred compounds of Formula (I), wherein Z comprises an acidic proton, can be represented 20 as either Formual (l-l) or (l-ll). For compounds of Formula (l-ll) emphasis is given to salts when Y is chloride, bromide, iodide, hydroxide, bicarbonate, acetate, pentafluoropropionate, triflate, trifluoroacetate, methylsulfate, tosylate and nitrate, wherein j and k are 1. Preferably, Y is chloride, bromide, iodide, hydroxide, bicarbonate, acetate, trifluoroacetate, methylsulfate, tosylate and nitrate, wherein j and k are 1. For compounds of Formula (l-ll) emphasis is also given to salts when Y is 25 carbonate and sulfate, wherein j is 2 and k is 1, and when Y is phosphate, wherein j is 3 and k is 1.
Where appropriate compounds of Formula (I) may also be in the form of (and/or be used as) an N-oxide.
Compounds of Formula (I) wherein m is 0 may be represented by a compound of Formula (l-la) as shown below:
wherein R1, R2, A and Z are as defined for compounds of Formula (I).
Compounds of Formula (I) wherein m is 1 may be represented by a compound of Formula (l-lb) as shown below:
Z
R2b (Mb) wherein R1, R2, R1a, R2b, A and Z are as defined for compounds of Formula (I).
Compounds of Formula (I) wherein m is 2 may be represented by a compound of Formula (l-lc) as shown below:
(l-lc) wherein R1, R2, R1a, R2b, A and Z are as defined for compounds of Formula (I).
Compounds of Formula (I) wherein m is 3 may be represented by a compound of Formula (l-ld) as shown below:
(Md) wherein R1, R2, R1a, R2b, A and Z are as defined for compounds of Formula (I).
Preferred values of A, R1, R2, R1a, R2b, R8, R10, R12, Q, Z, m and p are as set out below, and a compound of Formula (I) according for use in the invention may comprise any combination of said values, unless explictly stated otherwise. The skilled man will appreciate that values for any specified set of embodiments may be combined with values for any other set of embodiments where such combinations are not mutually exclusive, and where not explicitly stated to the contrary.
With respect to substituents R1 and R2, the following combinations may ail be found in compounds of Formula (I): R1 is hydrogen and R2 is hydrogen, R1 is methyl and R2 is hydrogen (or R1 is hydrogen and R2 is methyl), R1 is methyl and R2 is methyl. However, most commonly, R1 is hydrogen and R2 is hydrogen.
As stated herein, m is an integer of 0, 1 or 2. Preferably m is 1 or 2, and most preferably m is 1. Where m is 1, it is preferred that R1a and R2b are each independently selected from the group consisting of hydrogen, hydroxy and methyl. In such cases where m is 1, it is particularly preferred that at least one of R1a and R2b is hydrogen.
Where m is 2 or more, it is preferred that the R1a and R2b borne by the carbon atom adjoining the CR1CR2 moiety, are each independently selected from the group consisting of hydrogen, hydroxy and methyl, and more preferably that at least one of said R1a and R2b is hydrogen.
As stated herein A is 6-membered heteroaryl selected from the group consisting of:
A-V A-VI A-VII wherein the jagged line defines the point of attachment to the remaining part of a compound of Formula (l), p is 0, 1 or 2 and each R8 is independently selected from the group consisting of NH2, methyl and methoxy.
Where p is an integer of 2, it is preferred that each R8 is methyl. However, preferably p is 0 or 1.
In certain embodiments A is preferably A-l, A-ll or A-lll, and p is preferably 0 or 1. In such embodiments, where p is 0, the skilled man will appreciate that any nitrogen atom in A may be protonated.
Preferably Z is selected from the group consisting of: -C(O)OH, -C(O)OCH3, -S(O)2OH, C(O)OCH2C6H5, -C(O)OCbH5, -C(O)NHS(O)2N(CH3)2. More preferably Z is -C(O)OH or -S(O)2OH.
Spécifie compounds of Formula (I) for use in the invention as component (A), are described below in the Examples. These include compounds 1.001, 1.002, 1.003, 1.004, 1.005, 1.006, 1.007, 1.008, 1.009, 1.010, 1.011, 1.012, 1.013, 1.014, 1.015, 1.016, 1.017, 1.018, 1.019, 1.020, 1.021,1.022, 1.023, 1.024, 1.025, 1.026, 1.027, 1.028, 1.029, 1.030, 1.031, 1.032, 1.033, 1.034, 1.035, 2.001,2.002, 2.003, 2.004, 2.005, 2.006, 2.007, 2.008, 2.009, 2.010, and 2.011. Particularly preferred compounds of Formula (I) for use as component (A) in the invention are selected from 1.001, 1.002, 1.003, 1.004, 1.005, 1.006, 1.007, 1.008, 1.009, 1.010, 1.011,1.012, 1.013, 1.014, 1.015, 1.016, 1.017, 1.018, 1.019, 1.020, 1.021, 1.022, 1.023, 1.024, 1.025, 1.026, 1.027, 1.028, 1.029, 1.030, 1.031, 1.032, 1.033, 1.034 and 1.035. More preferred still are compounds 1.001, 1.002, 1.003, 1.010, 1.011, 1.021, 1.022, 1.023, 1.027, 1.030, 1.031,1.032, 1.034 and 1.035.
The compounds of Formula (I) may be prepared according to the following schemes, in which the substituents A, R1, R2, R1a, R2b, R8, R10, R12, Q, Z, m and p hâve (unless otherwise stated explicitly) the définitions described hereinbefore.
The compounds of Formula (I) may be prepared by the alkylation of compounds of formula (X), wherein A is as defined for compounds of Formula (I), with a suitable alkylating agent of formula (W), wherein R1, R2, Q,and Z are as defined for compounds of Formula (I) and LG is a suitable leaving group, for example, halide or pseudohalide such as triflate, mesylate or tosylate, in a suitable solvent at a suitable température, as described in reaction scheme 1. Example conditions include stirring a compound of formula (X) with an alkylating agent of formula (W) in a solvent, or mixture of solvents, such as acetone, dichloromethane, dichloroethane, Λ/,/V-dimethylformamide, acetonitrile, 1,4-dioxane, water, acetic acid ortrifluroacetic acid at a température between -78°C and 150°C. An alkylating agent of formula (W) may include, but is not limited to, bromoacetic acid, methyl bromoacetate, 3bromopropionoic acid, methyl 3-bromopropionate, 2-bromo-N-methoxyacetamide, sodium 2bromoethanesulphonate, 2,2-dimethylpropyl 2-(trifluoromethylsulfonyloxy)ethanesulfonate, 2-bromo-N5 methanesulfonylacetamide, 3-bromo-N-methanesulfonylpropanamide, and dimethoxyphosphorylmethyl trifluoromethanesulfonate. -Such alkylating agents and related compounds are either known in the literature or may be prepared by known literature methods. Compounds of Formula (I) which may be described as esters of N-alkyl acids, which include, but are not limited to, esters of carboxylic acids, phosphonic acids, phosphinic acids, sulfonic acids and sulfinic acids, may be 10 subsequently partially or fully hydrolysed by treament with a suitable reagent, for example, aqueous hydrochloric acid or trimethylsilyl bromide, in a suitable solvent at a suitable température between 0°C and 100°C.
Reaction scheme 1
LG Q /F Z
Rl/ R2 formula (W)
L II .N/
R2 15 formula <X> formula (I)
Additonally, compounds of Formula (I) may be prepared by reacting compounds of formula (X), wherein A is as defined for compounds of Formula (I), with a suitably activated electrophilic alkene of formula (B), wherein Z is -S(O)2OR10, or -C(O)OR10 and R1, R2, R1a, and R10 are as defined for compounds of Formula (I), in a suitable solvent at a suitable température. Compounds of formula (B) 20 are known in the literature, or may be prepared by known methods. Example reagents include, but are not limited to, acrylic acid, methacrylic acid, crotonic acid, 3,3-dimethylacrylic acid, methyl acrylate, ethene sulfonic acid, isopropyl ethylenesulfonate, and 2,2-dimethylpropyl ethenesulfonate. The direct products of these reactions, which may be described as esters of N-alkyl acids, which include, but are not limited to, esters of carboxylic acids and sulfonic acids, may be subsequently partially or fully 25 hydrolysed by treament with a suitable reagent in a suitable solvent at a suitable température, as described in réaction scheme 2.
Reaction scheme 2
formula (I), wherein m=1, and Z=S(O)2OR10, C(O)OR10 formula (I), wherein m=1, and Z=SO3H, C(O)OH
In a related reaction compounds of Formula (I), wherein Q is C(R1aR2b), m is 1,2 or 3 and Z is 5 S(O)2OH, may be prepared by the reaction of compounds of formula (X), wherein A is as defined for compounds of Formula (I), with a cyclic alkylating agent of formula (E), (F) or (AF), wherein Ya is C(R1aR2b), and R1, R2, R1a and R2b are as defined for compounds of Formula (I), in a suitable solvent at a suitable température, as described in reaction scheme 3.
Reaction scheme 3
formula (E), wherein m=1
formula (F), where m=2
formula (X) o—s=o
R2b
R
formula (I), wherein m is 1, 2 or 3, and Z=SO3H formula (AF) where m=1
Suitable solvents and suitable températures are as previously described. An alkylating agent of formula (E) or (F) may include, but is not limited to, 1,3-propanesultone, 1,4-butanesultone, ethylenesulfate, 1,3-propylene sulfate and 1,2,3-oxathiazolidine 2,2-dioxide. Such alkylating agents and related compounds are either known in the literature or may be prepared by known literature methods.
A compound of Formula (I), wherein m is 0, and Z is -S(O)2OH, may be prepared from a compound of Formula (I), wherein m is 0, and Z is C(O)OR10, by treatment with trimethylsilylchloro sulfonate in a suitable solvent at a suitable température, as described in reaction scheme 4. Preferred
conditions include heating the carboxylate precursor in neat trimethylsilylchlorosulfonate at a température between 25°C and 150°C.
Réaction scheme 4
formula (I) wherein m=0, and Z=C(O)OR10 formula (I), wherein m=0, and Z=SO3H
Furthermore, compounds of Formula (I) may be prepared by reacting compounds of formula (X), wherein A is as defined for compounds of Formula (I), with a suitable alcohol of formula (WJ\f), wherein R1, R2, Q, and Z are as defined for compounds of Formula (I), under Mitsunobu-type conditions such as those reported by Petit et al, Tet. Lett. 2008, 49 (22), 3663. Suitable phosphines include triphenylphosphine, suitable azodicarboxylates include diisopropylazodicarboxylate and suitable acids include fluoroboric acid, triflic acid and bis(trifluoromethylsulfonyl)amine, as described in reaction scheme 5. Such alcohols are either known in the literature or may be prepared by known literature methods.
Reaction scheme 5
HO Q
Acid, Ph3P
Compounds of Formula (I) may also be prepared by reacting compounds of formula (C), wherein Q, Z, R1, R2, and A are as defined for compounds of Formula (I), with a hydrazine of formula (D) in a 20 suitable solvent or mixture of solvents, in the presence of a suitable acid at a suitable température, between -78°C and 150°C, as described in reaction scheme 6. Suitable solvents, or mixtures thereof, include, but are not limited to, alcohols, such as methanol, éthanol and isopropanol, water, aqueous hydrochloric acid, aqueous sulfuric acid, acetic acid and trifluoroacetic acid. Hydrazine compounds of formula (D), for example 2,2-dimethylpropyl 2-hydrazinoethanesulfonate, are either known in the 25 literature or may be prepared by known literature procedures.
Reaction scheme 6
formula (C) formula (I)
R' = H, C1-C4alkyl,
C1-C4alkylcarbonyl
Compounds of formula (C) may be prepared by reacting compounds of formula (G), wherein A is as defined for compounds of Formula (I), with an oxidising agent in a suitable solvent at a suitable température, between -78°C and 150°C, optionally in the presence of a suitable base, as described in reaction scheme 7.
Reaction scheme 7
A
Base formula (G) formu|a (c)
R' = H, C1-C4alkyl, C1-C4alkyl carbonyl
Suitable oxidising agents include, but are not limited to, bromine and suitable solvents include, but are not limited to alcohols such as méthanol, éthanol and isopropanol. Suitable bases include, but are not limited to, sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate and potassium acetate. Similar reactions are known in the literature (for example Hufford, D. L.; Tarbell, D. S.; Koszalka, T. R. J. Amer. Chem. Soc., 1952, 3014). Furans of formula (G) are known in the literature or may be prepared using literature methods. Example methods include, but are not limited to, transition métal cross-couplings such as Stille (for example Farina, V.; Krishnamurthy, V.; Scott, W. J. Organic Reactions, Vol. 50. 1997, and Gazzard, L. et al. J. Med. Chem., 2015, 5053), Suzuki-Miyaura (for example Ando, S.; Matsunaga, H.; Ishizuka, T. J. Org. Chem. 2017, 1266-1272, and Ernst, J. B.; Rakers, L.; Glorius, F. Synthesis, 2017,260), Negishi (for example Yang, Y.; Oldenhius, N. J.; Buchwald, S. L. Angew. Chem. Int. Ed. 2013, 615, and Braendvang, M.; Gundersen, L. Bioorg. Med. Chem. 2005, 6360), and Kumada (for example Heravi, Μ. M.; Hajiabbasi, P. Monatsh. Chem., 2012, 1575). The coupling partners may be selected with reference to the spécifie cross-coupling reaction and target product. Transition métal catalysts, ligands, bases, solvents and températures may be selected with reference to the desired cross-coupling and are known in the literature. Cross-coupling reactions using pseudo halogens, including but not limited to, triflates, mesylates, tosylates and anisoles, may also be achieved under related conditions.
In another approach a compound of Formula (I), wherein Q, Z, R1, R2, and A are as defined for compounds of Formula (I), may be prepared from a compound of formula (R) and an oxidant, in a suitable solvent at a suitable température, as outlined in reaction scheme 8. Example oxidants include, but are not limited to, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, tetrachloro-p-benzoqumone, potassium permanganate, manganèse dioxide, 2,2,6,6-tetramethyl-1-piperidinyloxy and bromine. Related reactions are known in the literature.
Reaction scheme 8
formula (R) formula (I)
A compound of formula (R), wherein Q, Z, R1, R2, and A are as defined for compounds of Formula (I), may be prepared from a compound of formula (S), wherein Q, Z, X, n, R1, and R2 are as defined for compounds of Formula (I), and an organometallic of formula (T), wherein A is as defined for compounds of Formula (I) and M” includes, but is not limited to, organomagnesium, organolithium, organocopper and organozinc reagents, in a suitable solvent at a suitable température, optionally in the presence of an additonal transition métal additive, as outlined in reaction scheme 9. Example conditions include treating a compound of formula (S) with a Grignard of formula (T), in the presence of 0.05-100 mol% copper iodide, in a solvent such as tetrahydrofuran at a température between -78°C and 100°C. Organometallics of formula (T) are known in the literature, or may be prepared by known literature methods. Compounds of formula (S) may be prepared by analogous reactions to those for the préparation of compounds of Formula (I) from a compound of formula (XX).
Reaction scheme 9
formula (S) formula (R)
Biaryl pyridazines of formula (X) are known in the literature or may be prepared using literature methods. Example methods include, but are not limited to, the transition métal cross-coupling of compounds of formula (H) and formula (J), or alternatively compounds of formula (K) and formula (L), in which compounds of formula (J) and formula (L), wherein M’ is either an organostannane, organoboronic acid or ester, organotrifluoroborate, organomagnesium, organocopper or organozinc, as outlined in reaction scheme 10. Hal is defined as a halogen or pseudo halogen, for example triflate, mesylate and tosylate. Such cross-couplings include Stille (for example Sauer, J.; Heldmann, D. K. Tetrahedron, 1998, 4297), Suzuki-Miyaura (for example Luebbers, T.; Flohr, A.; Jolidon, S.; DavidPierson, P.; Jacobsen, H.; Ozmen, L.; Baumann, K. Bioorg. Med. Chem. Lett., 2011,6554), Negishi (for example Imahori, T.; Suzawa, K.; Kondo, Y. Heterocycles, 2008, 1057), and Kumada (for example Heravi, Μ. M.; Hajiabbasi, P. Monatsh. Chem., 2012,1575). The coupling partners may be selected with reference to the spécifie cross-coupling reaction and target product. Transition métal catalysts, ligands, bases, solvents and températures may be selected with reference to the desired cross-coupling and are known in the literature. Compounds of formula (H), formula (K) and formula (L) are known in the literature, or may be prepared by known literature methods.
Reaction scheme 10
A —Hal +
formula (J)
Transition métal catalyst Ligand
formula (H) formula (X)
Transition métal catalyst Ligand
formula (L) formula (K) formula (X)
A compound of formula (J), wherein M’ is either an organostannane, organoboronic acid or ester, organotrifluoroborate, organomagnesium, organocopper or organozinc, may be prepared from a 10 compound of formula (XX), by metallation, as outlined in reaction scheme 11. Similar reactions are known in the literature (for example Ramphal et al, WO2015/153683, Unsinn et al., Organic Letters, 15(5), 1128-1131; 2013, Sadler et al., Organic & Biomolecular Chemistry, 12(37), 7318-7327; 2014. Alternatively, an organometallic of formula (J) may be prepared from compounds of formula (K), wherein Hal is defined as a halogen or pseudo halogen, for example triflate, mesylate and tosylate, as described 15 in scheme 11. Example conditions to préparé an compound of formula (J) wherein M’ is an organostannane, include treatment of a compound of formula (K) with lithium tributyl tin in an appropriate solvent at an appropriate température (for example see WO 2010/038465). Example conditions to préparé compound of formula (J) wherein M’ is an organoboronic acid or ester, include treatment of a compound of formula (K) with bis(pinacolato)diboron, in the presence of an appropriate transition métal 20 catalyst, appropriate ligand, appropriate base, in an appropriate solvent at an appropriate température (for example KR 2015135626). Compounds of formula (K) and formula (XX) are either known in the literature or can be prepared by known methods.
Reaction scheme 11
formula (K)
formula (J)
formula (XX)
Compositions ofthe invention also comprise, as component (B), at least one herbicide, or sait thereof, selected from the group consisting of:
B1 a non-selective herbicide selected from the group consisting of glyphosate, glufosinate, 5 hydantocidin, pelargonic acid, paraquat and diquat;
B2 a herbicide that acts through the inhibition of protoporphoryinogen oxidase; and
B3 a herbicide that inhibits photosystem II in photosynthesis.
Some ofthe herbicides of component B are commonly used in the form of agronomically acceptable salts. Where a spécifie herbicide is described as being suitable for use as component B, 10 the skilled man will appreciate that this includes any suitable agronomically aceptable sait of that herbicide, for example any sait which may form with amines (for example ammonia, dimethylamine and triethylamine), alkali métal and alkaline earth métal bases orquatemary ammonium bases. Among the alkali métal and alkaline earth métal hydroxides, oxides, alkoxides and hydrogen carbonates and carbonates used as sait formers, emphasis is to be given to the hydroxides, alkoxides, 15 oxides and carbonates of lithium, sodium, potassium, magnésium and calcium, but especially those of sodium, magnésium and calcium. The corresponding trimethylsulfonium sait may also be used. The présent invention also include the use of hydrates which may be formed during the sait formation for any herbicide of component B.
Herbicides that act through the inhibition of protoporphoryinogen oxidase, and are thus included 20 in group B2, include the diphenyl ethers (bifenox, ethoxyfen-ethyl, halosafen, lactofen, acifluorfensodium, chlomethoxyfen, fluoroglycofen-ethyl, oxyfluorfen, fomesafen), the thiadiazoles (fluthiacetmethyl, thidazimin), the phenylpyrazoles (fluazolate, pyraflufen-ethyl), the oxadiazoles (oxadiargyl, oxadiazon), the N-phenylphthalimides (cinidon-ethyl, flumiclorac-pentyl, flumioxazin), the pyrmidinediones (benzfendizone, butafenacil, saflufenacil), the triazolinones (azafenidin, 25 bencarbazone, carfentrazone-ethyl, sulfentrazone), the oxazolidinedione pentoxazone, as well as flufenpyr ethyl, pyraclonil, profluazol, the compound of formula B2.9
B2.9, and the compound of B2.10
Preferred herbicides from B2 for use in the invention are selected from the group consisting of:
B2(i) saflufenacil, B2(ii) fomesafen, B2(iii) oxyfluorfen, B2(iv) butafenacil, B2(v) carfentrazoneethyl, B2(vi) pyraflufen-ethyl, B2(vii) sulfentrazone, B2(vni) flumioxazm, B2(ix) compound B2.9,
More preferred herbicides from B2 for use in the invention are selected from the group consisting of: B2(i) saflufenacil, B2(ii) fomesafen, B2(iii) oxyfluorfen, B2(iv) butafenacil, B2(v) carfentrazone-ethyl, B2(vi) pyraflufen-ethyl, B2(vii) sulfentrazone, B2(viii) flumioxazin, and B2(ix) compound B2.9,
Herbicides that inhibit photosystem II in photosynthesis, and are thus included in group B3, include the pyridazinone chloridazon/pyrazon, the phenyl carbamates (desmedipham, desmedipham), the uracils (bromacil, lenacil, terbacil, tiafenacil), the triazinones (hexazinone, metamitron, metribuzin), the ureas (fenuron, metobromuron, neburon, chlorobromuron, fluometuron, methabenzthiazuron, siduron, chlorotoluron, isoproturon, metoxuron, tebuthiuron, chloroxuron, isouron, monlinuron, dimefuron, linuron, diuron, ethidimuron), the triazolinone amicarbozone, the triazines (atrazine, desmetryne, propazine, terbuthylazine, dimethametryn, simetryne, terbutryne, ametryne, prometon, simazine, trietazine, prometryne, terbumeton), the amides (pentanochlor, propanil), the nitriles (bromofenoxim, bromoxynil, ioxynil), the phenyl-pyridazines (pyridate, pyridafol), and the benzothiadiazinone bentazone.
Preferred herbicides from B3 for use in the invention are selected from the group consisting of: B3(i) atrazine, B3(ii) ametryn, B3(iii) metribuzin, B3(iv) hexazinone, B3(v) diuron, B3(vi) propanil, B3(vii) prometryn, B3(viii) tiafenacil, and B3(ix) trifludimoxazin.
Herbicides of groups B1, B2 and B3 as described above, are well known in the art, and can either be obtained commercially, or manufactured using methods available in the art.
In Tables 1 to 3 below, 840 spécifie combinations of components A and B, are described according to the invention.
Table 1 Compositions of the invention comprising as component (A), a compound of Formula (I) and as 5 component (B), a herbicide from group B1. This table explicitly recites 210 spécifie compositions of the invention (M1 to M204, and M817 to M822 respectively), wherein the compound of Formula (I) is specified in column 1, and the herbicide of component (B) is specified in columns 2 to 7 respectively.
1.001 COMPONENT (B)
Glyphosate Glufosinate Hydantocidin Pelargonic Acid Paraquat Diquat
M1 M35 M69 M103 M137 M171
1.002 M2 M36 M70 M104 M138 M172
1.003 M3 M37 M71 M105 M139 M173
1.004 M4 M38 M72 M106 M140 M174
1.005 M5 M39 M73 M107 M141 M175
1.006 M6 M40 M74 M108 M142 M176
1.007 M7 M41 M75 M109 M143 M177
1.008 M8 M42 M76 M110 M144 M178
1.009 M9 M43 M77 M111 M145 M179
1.010 M10 M44 M78 M112 M146 M180
1.011 M11 M45 M79 M113 M147 M181
1.012 M12 M46 M80 M114 M148 M182
„ 1.013 M13 M47 M81 M115 M149 M183
T 1.014 M14 M48 M82 M116 M150 M184
<= 1.015 M15 M49 M83 M117 M151 M185
A E 1.016 M16 M50 M84 M118 M152 M186
s ü 1.017 M17 M51 M85 M119 M153 M187
O £ 1.018 M18 M52 M86 M120 M154 M188
Ξ = 1.019 M19 M53 M87 M121 M155 M189
8 g- 1.020 M20 M54 M88 M122 M156 M190
o 1.021 M21 M55 M89 M123 M157 M191
“ 1.022 M22 M56 M90 M124 M158 M192
1.023 M23 M57 M91 M125 M159 M193
1.024 M24 M58 M92 M126 M160 M194
1.025 M25 M59 M93 M127 M161 M195
1.026 M26 M60 M94 M128 M162 M196
1.027 M27 M61 M95 M129 M163 M197
1.028 M28 M62 M96 M130 M164 M198
1.029 M29 M63 M97 M131 M165 M199
1.030 M30 M64 M98 M132 M166 M200
1.031 M31 M65 M99 M133 M167 M201
1.032 M32 M66 M100 M134 M168 M202
1.033 M33 M67 M101 M135 M169 M203
1.034 M34 M68 M102 M136 M170 M204
1.035 M817 M818 M819 M820 M821 M822
Table 2 Compositions of the invention comprising as component (A), a compound of Formula (I) and as component (B), a herbicide from group B2. This table explicitly recites 350 spécifie compositions of the invention (M205 to M510, M823 to M831, and M841 to M875) wherein the compound of Formula (I) is specified in column 1, and the herbicide of component (B) is specified in columns 2 to 11 respectively.
„ 1001 COMPONENT (B)
Saflufen -acil Fomesafen Oxyfluorfen Butafenacil Carfentrazone-ethyl Pyrafluf en-ethyl Sufentrazone Flumioxazin B2.9 B2.10
M205 M239 M273 M307 M341 M375 M409 M443 M477 M841
— 2 1002 M206 M240 M274 M308 M342 M376 M410 M444 M478 M842
S 1.003 M207 M241 M275 M309 M343 M377 M411 M445 M479 M843
z i 1.004 M208 M242 M276 M310 M344 M378 M412 M446 M480 M844
z -o = 1.005 M209 M243 M277 M311 M345 M379 M413 M447 M481 M845
& g 1006 M210 M244 M278 M312 M346 M380 M414 M448 M482 M846
O g· 1.007 M211 M245 M279 M313 M347 M381 M415 M449 M483 M847
° S 1.008 M212 M246 M280 M314 M348 M382 M416 M450 M484 M848
“ 1.009 M213 M247 M281 M315 M349 M383 M417 M451 M485 M849
COMPONENT (B)
Saflufen -acil Fomesafen Oxyfluorfen Butafenacil Carfentrazone-ethyl Pyraflufen-ethyl Sufentrazone Flumioxazin B2.9 B2.10
1.010 M214 M248 M282 M316 M350 M384 M418 M452 M486 M850
1.011 M215 M249 M283 M317 M351 M385 M419 M453 M487 M851
1.012 M216 M250 M284 M318 M352 M386 M420 M454 M488 M852
1.013 M217 M251 M285 M319 M353 M387 M421 M455 M489 M853
1.014 M218 M252 M286 M320 M354 M388 M422 M456 M490 M854
1.015 M219 M253 M287 M321 M355 M389 M423 M457 M491 M855
1.016 M220 M254 M288 M322 M356 M390 M424 M458 M492 M856
1.017 M221 M255 M289 M323 M357 M391 M425 M459 M493 M857
1.018 M222 M256 M290 M324 M358 M392 M426 M460 M494 M858
1.019 M223 M257 M291 M325 M359 IVI393 M427 M461 M495 M859
1.020 M224 M258 M292 M326 M360 M394 M428 M462 M496 M860
1.021 M225 M259 M293 M327 M361 M395 M429 M463 M497 M861
1.022 M226 M260 M294 M328 M362 M396 M430 M464 M498 M862
1.023 M227 M261 M295 M329 M363 M397 M431 M465 M499 M863
1.024 M228 M262 M296 M330 M364 M398 M432 M466 M500 M864
1.025 M229 M263 M297 M331 M365 M399 M433 M467 M501 M865
1.026 M230 M264 M298 M332 M366 M400 M434 M468 M502 M866
1.027 M231 M265 M299 M333 M367 M401 M435 M469 M503 M867
1.028 M232 M266 M300 M334 M368 M402 M436 M470 M504 M868
1.029 M233 M267 M301 M335 M369 M403 M437 M471 M505 M869
1.030 M234 M268 M302 M336 M370 M404 M438 M472 M506 M870
1.031 M235 M269 M303 M337 M371 M405 M439 M473 M507 M871
1.032 M236 M270 M304 M338 M372 M406 M440 M474 M508 M872
1.033 M237 M271 M305 M339 M373 M407 M441 M475 M509 M873
1.034 M238 M272 M306 M340 M374 M408 M442 M476 M510 M874
1.035 M823 M824 M825 M826 M827 M828 M829 M830 M831 M875
Table 3 Compositions of the invention comprising as component (A), a compound of Formula (I) and as component (B), a herbicide from group B3. This table explicitly recites 315 spécifie compositions of the invention (M511 to M816, and M832 to M840) wherein the compound of Formula (I) is specified in column 1, and the herbicide of component (B) is specified in columns 2 to 10 respectively.
1.001 COMPONENT (B)
Atrazine Ametryn Metribuzin Hexazinone Diuron Propanil Prometryn Tiafenacil Trifludimoxazin
M511 M545 M579 M613 M647 M681 M715 M749 M783
1.002 M512 M546 M580 M614 M648 M682 M716 M750 M784
1.003 M513 M547 M581 M615 M649 M683 M717 M751 M785
1.004 M514 M548 M582 M616 M650 M684 M718 M752 M786
1.005 M515 M549 M583 M617 M651 M685 M719 M753 M787
1.006 M516 M550 M584 M618 M652 M686 M720 M754 M788
1.007 M517 M551 M585 M619 M653 M687 M721 M755 M789
1.008 M518 M552 M586 M620 M654 M688 M722 M756 M790
1.009 M519 M553 M587 M621 M655 M689 M723 M757 M791
1.010 M520 M554 M588 M622 M656 M690 M724 M758 M792
= 1.011 M521 M555 M589 M623 M657 M691 M725 M759 M793
rç 1.012 M522 M556 M590 M624 M658 M692 M726 M760 M794
É 1.013 M523 M557 M591 M625 M659 M693 M727 M761 M795
£ 1.014 M524 M558 M592 M626 M660 M694 M728 M762 M796
o 1.015 M525 M559 M593 M627 M661 M695 M729 M763 M797
T 1.016 M526 M560 M594 M628 M662 M696 M730 M764 M798
S 1.017 M527 M561 M595 M629 M663 M697 M731 M765 M799
E 1.018 M528 M562 M596 M630 M664 M698 M732 M766 M800
Si 1.019 M529 M563 M597 M631 M665 M699 M733 M767 M801
< 1.020 M530 M564 M598 M632 M666 M700 M734 M768 M802
t= 1.021 M531 M565 M599 M633 M667 M701 M735 M769 M803
s 1.022 M532 M566 M600 M634 M668 M702 M736 M770 M804
o 1.023 M533 M567 M601 M635 M669 M703 M737 M771 M805
Ξ 1.024 M534 M568 M602 M636 M670 M704 M738 M772 M806
8 1.025 M535 M569 M603 M637 M671 M705 M739 M773 M807
1.026 M536 M570 M604 M638 M672 M706 M740 M774 M808
1.027 M537 M571 M605 M639 M673 M707 M741 M775 M809
1.028 M538 M572 M606 M640 M674 M708 M742 M776 M810
1.029 M539 M573 M607 M641 M675 M709 M743 M777 M811
1.030 M540 M574 M608 M642 M676 M710 M744 M778 M812
1.031 M541 M575 M609 M643 M677 M711 M745 M779 M813
1.032 M542 M576 M610 M644 M678 M712 M746 M780 M814
1.033 M543 M577 M611 M645 M679 M713 M747 M781 M815
1.034 M544 M578 M612 M646 M680 M714 M748 M782 M816
1.035 M832 M833 M834 M835 M836 M837 M838 M839 M840
In one set of embodiments, it is preferred that component B is selected from the group consisting 10 of glyphosate, glufosinate, hydantocidin, diquat; B2(i) saflufenacil, B2(ii) fomesafen, B2(iii) oxyfluorfen, B3(i) atrazine, and B3(iii) metribuzin.
Throughout this document the expression “composition” should be interpreted as meaning the various mixtures or combinations of components (A) and (B), for example in a single “ready-mix” form, in a combined spray mixture composed from separate formulations ofthe single active ingrédient components, such as a “tank-mix”, and in a combined use ofthe single active ingrédients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the components (A) and (B) is not essential for working the présent invention.
The term “herbicide” as used herein means a compound that contrais or modifies the growth of plants. The term “herbicidally effective amount” means the quantity of such a compound or combination of such compounds that is capable of producing a controlling or modifying effect on the growth of plants. Controlling or modifying effects include ail déviation from natural development, for 5 example killing, retardation, leaf burn, albinism, dwarfing and the like.
The term “locus” as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established végétation.
The term “plants” refers to ail physical parts of a plant, including seeds, seedlings, saplings, 10 roots, tubers, stems, stalks, foliage, and fruits.
The term plant propagation material” dénotés ail generative parts of a plant, for example seeds or végétative parts of plants such as cuttings and tubers. It includes seeds in the strict sense, as well as roots, fruits, tubers, bulbs, rhizomes, and parts of plants.
The term “safener” as used herein means a Chemical that when used in combination with a 15 herbicide reduces the undesirabie effects ofthe herbicide on non-target organisms, for example, a safener protects crops from injury by herbicides but does not prevent the herbicide from killing the weeds.
Crops of useful plants in which the composition according to the invention can be used include perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, 20 raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed râpe (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, 25 fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, 30 aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
Crops are to be understood as being those which are naturally occurring, obtained by conventional methods of breeding, or obtained by genetic engineering. They include crops which contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved 35 flavour).
Crops are to be understood as also including those crops which hâve been rendered tolérant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO-, ACCase- and HPPD-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolérant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® 40 summer râpe (canola). Examples of crops that hâve been rendered tolérant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available underthe trade names RoundupReady®and Liberty Lin k®.
Crops are also to be understood as being those which hâve been rendered résistant to harmful insects by genetic engineering methods, for example Bt maize (résistant to European corn borer), Bt cotton (résistant to cotton boll weevil) and also Bt potatoes (résistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds). The Bt toxin is a protein that is formed naturally by Bacillus thuringiensis soil bacteria. Examples of toxins, or transgenic plants able to synthesise such toxins, are described in EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes that code for an insecticidal résistance and express one or more toxins are KnockOut® (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®. Plant crops or seed material thereof can be both résistant to herbicides and, at the same time, résistant to insect feeding (stacked transgenic events). For example, seed can hâve the ability to express an insecticidal Cry3 protein while at the same time being tolérant to glyphosate.
Compositions ofthe invention can typically be used to control a wide variety of monocotyledonous and dicotyledonous weed species. Examples of monocotyledonous species that can typically be controlled include Alopecurus myosuroides, Avena fatua, Brachiaria plantaginea, Bromus tectorum, Cyperus esculentus, Digitaria sanguinalis, Echinochloa crus-galli, Lolium perenne, Lolium multiflorum, Panicum miliaceum, Poa annua, Setaria viridis, Setaria faberi and Sorghum bicolor. Examples of dicotyledonous species that can be controlled include Abutilon theophrasti, Amaranthus retroflexus, Bidens pilosa, Chenopodium album, Euphorbia heterophylla, Galium aparine, Ipomoea hederacea, Kochia scoparia, Polygonum convolvulus, Sida spinosa, Sinapis arvensis, Solanum nigrum, Stellaria media, Veronica persica and Xanthium strumarium.
In ail aspects ofthe invention, in any particular embodiment, the weeds, e.g. to be controlled and/or growth-inhibited, may be monocotyledonous or dicotyledonous weeds, which are tolérant or résistant to one or more other herbicides for example, HPPD inhibitor herbicides such as mesotrione, PSII inhibitor herbicides such as atrazine or EPSPS inhibitors such as glyphosate. Such weeds include, but are not limited to résistant Amaranthus biotypes.
Compositions of this invention can also be mixed with one or more further pesticides including herbicides [typically different to the herbicides of Formula (I) and those of component (B)] fungicides, insecticides, nematocides, bactéricides, acaricides, growth regulators, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection.
Similarly compositions ofthe invention (which includes those comprising one or more additional pesticide as described in the preceding paragraph) can further include one or more safeners. In particular, the following safeners are especially preferred: AD 67 (MON 4660), benoxacor, cloquintocet-mexyl, cyometrinil, cyprosulfamide, dichlormid, dicyclonon, dietholate, fenchlorazoleethyl, fenclorim, flurazole, fluxofenim, furilazole, furilazome, isoxadifen-ethyl, mefenpyr-diethyl, mephenate, oxabetrinil, naphthalic anhydride (CAS RN 81-84-5), TI-35, N-isopropyl-4-(2-methoxybenzoylsulfamoyl)-benzamide (CAS RN 221668-34-4) and N-(2-methoxybenzoyl)-420326
[(methylaminocarbonyl)amino]benzenesulfonamide. Such safeners may also be used in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 15th Ed. (BCPC), 2009. Thus, the reference to cloquintocet-mexyl also applies to cloquintocet and to a lithium, sodium, potassium, calcium, magnésium, aluminium, iron, ammonium, quaternary ammonium, sulfonium or phosphonium sait thereof as disclosed in WO02/34048 and the reference to fenchlorazole-ethyl also applies to fenchlorazole, etc.
The compositions ofthe invention can be applied before or after planting ofthe crops, before weeds emerge (pre-emergence application) or after weeds emerge (post-emergence application). Where a safener is combined with mixtures ofthe invention, it is preferred that the mixing ratio of compound of Formula (I) to safener is from 100:1 to 1:10, especially from 20:1 to 1:1.
It is possible that the safener and the compositions ofthe invention are applied simultaneously. For example, the safener and the composition of the invention might be applied to the locus preemergence or might be applied to the crop post-emergence. It is also possible that the safener and the composition ofthe invention are applied sequentially. For example, the safener might be applied before sowing the seeds as a seed treatment and the composition ofthe invention might be applied to the locus pre-emergence or might be applied to the crop post-emergence.
However, the skilled man will appreciate that compositions of the invention are particularly useful in non-selective burn-down applications, and as such may also be used to control volunteer or escape crop plants. In such situations, it is clearly not necessary to include a safener in a composition 20 ofthe invention.
In general, the mixing ratio (by weight) ofthe compound of Formula (I) to the compound of component B is from 0.01:1 to 100:1, more preferably from 0.025:1 to 20:1, even more preferably from 1:30 to 20:1. Thus, the preferred ratio ranges for preferred compositions ofthe invention are given in Table 4 below.
Table 4: Exemplar ratio ranges for spécifie compositions of the invention____________
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M1 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M2 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M3 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M4 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M5 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M6 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M7 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M8 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M9 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M10 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M11 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M12 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M13 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M14 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M15 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M16 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M17 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M18 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M19 0.01:1 to 100:1 0.025:1 to20:1 1:30 to 16:1
M20 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M21 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M22 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M23 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M24 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M25 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M26 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M27 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M28 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M29 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M30 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M31 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M32 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M33 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M34 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M35 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M36 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M37 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M38 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M39 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M40 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M41 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M42 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M43 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M44 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M45 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M46 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M47 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M48 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M49 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M50 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M51 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M52 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M53 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M54 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M55 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M56 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M57 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M58 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M59 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M60 0.01:1 to 100:1 0,025:1 to 20:1 1:30 to 16:1
M61 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M62 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M63 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M64 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M65 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M66 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M67 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M68 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M69 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M70 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M71 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M72 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M73 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M74 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M75 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M76 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M77 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M78 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M79 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M80 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M81 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M82 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M83 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M84 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M85 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M86 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M87 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M88 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M89 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M90 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M91 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M92 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M93 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M94 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M95 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M96 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M97 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M98 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M99 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M100 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M101 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M1C2 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M103 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M104 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M105 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M106 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M107 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M108 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M109 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M110 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M111 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M112 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M113 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M114 0.01:1 to 100:1 0.025:1 to20:1 1:30 to 16:1
M115 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M116 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M117 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M118 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M119 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M120 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M121 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M122 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M123 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M124 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M125 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M126 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M127 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M128 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M129 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M130 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M131 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M132 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M133 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M134 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M135 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M136 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M137 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M138 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M139 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M140 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M141 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M142 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M143 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M144 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M145 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M146 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M147 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M148 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M149 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M150 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M151 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M152 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M153 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M154 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M155 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M156 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M157 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M158 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M159 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M160 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M161 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M162 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M163 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M164 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M165 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M166 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M167 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M168 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M169 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M170 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M171 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M172 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M173 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M174 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M175 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M176 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M177 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M178 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M179 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M180 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M181 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M182 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M183 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M184 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M185 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M186 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M187 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M188 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M189 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M190 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M191 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M192 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M193 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M194 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M195 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M196 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M197 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M198 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M199 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M200 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M201 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M202 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M203 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M204 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M205 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M206 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M207 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M208 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M209 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M210 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M211 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M212 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M213 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M214 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M215 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M216 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M217 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M218 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M219 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M220 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M221 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M222 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M223 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M224 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M225 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M226 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M227 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M228 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M229 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M230 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M231 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M232 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M233 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M234 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M235 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M236 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M237 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M238 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M239 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M240 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M241 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M242 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M243 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M244 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M245 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M246 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M247 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M248 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M249 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M250 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M251 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M252 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M253 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M254 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M255 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M256 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M257 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M258 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M259 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M260 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M261 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M262 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M263 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M264 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M265 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M266 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M267 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M268 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M269 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M270 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M271 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M272 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M273 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M274 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M275 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M276 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M277 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M278 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M279 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M280 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M281 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M282 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M283 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M284 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M285 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M286 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M287 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M288 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M289 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M290 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M291 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M292 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M293 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M294 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M295 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M296 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M297 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M298 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M299 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M300 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M301 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M302 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M303 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M304 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M305 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M306 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M307 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M308 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M309 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M310 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M311 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M312 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M313 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M314 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M315 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M316 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M317 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M318 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M319 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M320 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M321 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M322 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M323 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M324 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M325 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M326 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M327 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M328 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M329 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M330 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M331 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M332 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M333 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M334 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M335 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M336 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M337 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M338 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M339 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M340 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M341 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M342 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M343 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M344 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M345 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M346 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M347 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M348 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M349 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M350 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M351 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M352 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M353 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M354 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M355 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M356 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M357 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M358 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M359 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M360 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M361 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M362 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M363 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M364 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M365 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M366 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M367 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M368 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M369 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M370 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M371 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M372 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M373 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M374 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M375 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M376 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M377 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M378 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M379 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M380 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M381 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M382 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M383 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M384 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M385 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M386 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M387 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M388 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M389 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M390 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M391 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M392 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M393 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M394 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M395 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M396 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M397 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M398 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M399 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M400 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M401 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M402 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M403 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M404 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M405 0.01:1 to 100:1 0.025:1 ta 20:1 1:30 to 16:1
M406 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M407 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M408 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M409 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M410 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M411 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M412 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M413 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M414 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M415 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M416 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M417 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M418 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M419 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M420 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M421 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M422 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M423 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M424 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M425 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M426 0.01:1 to 100:1 0.025:1 ta 20:1 1:30 to 16:1
M427 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M428 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M429 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M430 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M431 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M432 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M433 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M434 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M435 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M436 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M437 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M438 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M439 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M440 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M441 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M442 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M443 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M444 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M445 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M446 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M447 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M448 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M449 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M450 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M451 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M452 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M453 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M454 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M455 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M456 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M457 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M458 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M459 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M460 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M461 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M462 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M463 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M464 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M465 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M466 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M467 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M468 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M469 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M470 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M471 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M472 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M473 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M474 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M475 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M476 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M477 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M478 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M479 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M480 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M481 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M482 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M483 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M484 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M485 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M486 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M487 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M488 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M489 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M490 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M491 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M492 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M493 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M494 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M495 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M496 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M497 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M498 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M499 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M500 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M501 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M502 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M503 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M504 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M505 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M506 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M507 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M508 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M509 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M510 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M511 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M512 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M513 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M514 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M515 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M516 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M517 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M518 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M519 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M520 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M521 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M522 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M523 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M524 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M525 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M526 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M527 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M528 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M529 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M530 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M531 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M532 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M533 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M534 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M535 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M536 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M537 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M538 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M539 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M540 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M541 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M542 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M543 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M544 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M545 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M546 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M547 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M548 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M549 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M550 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M551 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M552 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M553 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M554 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M555 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M556 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M557 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M558 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M559 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M560 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M561 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M562 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M563 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M564 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M565 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M566 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M567 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M568 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M569 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M570 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M571 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M572 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M573 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M574 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M575 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M576 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M577 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M578 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M579 0.01:1 to 100:1 0.025:1 to20:1 1:30 to 16:1
M580 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M581 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M582 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M583 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M584 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M585 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M586 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M587 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M588 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M589 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M590 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M591 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M592 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M593 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M594 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M595 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M596 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M597 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M598 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M599 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M600 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M601 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M602 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M603 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M604 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M605 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M606 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M607 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M608 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M609 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M610 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M611 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M612 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M613 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M614 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M615 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M616 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M617 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M618 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M619 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M620 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M621 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M622 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M623 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M624 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M625 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M626 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M627 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M628 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M629 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M630 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M631 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M632 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M633 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M634 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M635 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M636 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M637 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M638 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M639 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M640 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M641 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M642 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M643 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M644 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M645 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M646 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M647 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M648 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M649 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M650 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M651 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M652 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M653 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M654 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M655 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M656 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M657 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M658 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M659 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M660 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M661 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M662 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M663 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M664 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M665 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M666 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M667 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M668 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M669 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M670 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M671 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M672 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M673 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M674 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M675 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M676 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M677 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M678 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M679 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M680 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M681 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M682 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M683 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M684 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M685 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M686 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M687 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M688 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M689 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M690 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M691 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M692 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M693 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M694 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M695 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M696 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M697 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M698 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M699 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M700 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M701 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M702 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M703 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M704 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M705 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M706 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M707 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M708 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M709 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M710 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M711 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M712 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M713 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M714 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M715 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M716 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M717 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M718 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M719 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M720 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M721 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M722 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M723 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M724 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M725 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M726 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M727 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M728 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M729 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M730 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M731 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M732 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M733 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M734 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M735 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M736 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M737 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M738 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M739 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M740 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M741 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M742 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M743 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M744 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M745 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M746 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M747 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M748 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M749 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M750 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M751 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M752 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M753 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M754 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M755 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M756 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M757 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M758 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M759 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M760 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M761 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M762 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M763 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M764 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M765 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M766 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M767 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M768 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M769 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M770 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M771 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M772 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M773 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M774 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M775 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M776 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M777 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M778 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
Composition Number Typical Weight Ratio Preferred Weight Ratio More Preferred Weight Ratio
M779 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M780 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M781 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M782 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M783 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M784 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M785 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M786 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M787 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M788 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M789 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M790 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M791 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M792 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M793 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M794 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M795 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M796 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M797 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M798 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M799 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M800 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M801 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M802 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M803 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M804 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M805 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M806 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M807 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M808 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M809 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M810 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M811 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M812 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M813 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M814 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M815 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M816 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M817 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M818 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M819 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M820 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M821 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M822 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M823 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M824 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M825 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M826 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M827 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M828 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M829 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M830 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M831 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M832 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M833 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M834 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M835 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M836 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M837 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M838 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M839 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M840 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M841 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
35
Composition Typical Weight Preferred Weight More Preferred
Number Ratio Ratio Weight Ratio
M842 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M843 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M844 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M845 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M846 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M847 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M848 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M849 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M850 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M851 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M852 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M853 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M854 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M855 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M856 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M857 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M858 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M859 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M860 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M861 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M862 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M863 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M864 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M865 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M866 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M867 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M868 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M869 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M870 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M871 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M872 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M873 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M874 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
M875 0.01:1 to 100:1 0.025:1 to 20:1 1:30 to 16:1
The skilled man will appreciate that the most preferred ratio range of A:B for any one of composition numbers M1 to M875 described in Table 4 above is from 1:30 to 20:1, and that each one of composition numbers M1 to M875 described in Table 4 may used at any one ofthe following individualised ratios: 1:30, 1:15, 2:15, 3:20, 1:6, 1:5, 1:4, 4:15, 3:10, 1:3, 5:14, 3:8, 2:5, 8:15, 3:5, 5:7, 3:4, 4:5, 1:2, 1:1, 16:15, 6:5, 4:3, 10:7, 3:2, 8:5, 5:3, 2:1, 12:5, 8:3, 20:7, 16:5, 10:3, 4:1,8:1, 12:1, and 16:1.
When applied in a composition ofthe invention component (A) is typically applied at a rate of 50 to 2000 g ha, more particularly 50, 75, 100, 125, 150, 200, 250, 300, 400, 500, 750, 800, 1000, 1250, 10 1500, 1800, or 2000 g/ha. Such rates of component (A) are applied typically in association with 5 to 2000g/ha of component B, and more specifically in association with 5, 10, 15, 20, 25, 50, 75, 100, 125, 140, 150, 200, 250, 300, 400, 500, 750, 1000, 1250, 1500, 1800, or2000g/ha of component (B). The Examples described herein illustrate but fo not limit the range of rates of components A and B that may be employed in the invention.
The amount of a composition according to the invention to be applied, will dépend on various factors, such as the compounds employed; the subject ofthe treatment, such as, for example plants, soil or seeds; the type of treatment, such as, for example spraying, dusting orseed dressing; orthe application time. In agricultural practice the application rates ofthe composition according to the invention dépend on the type of effect desired, and typically range from 55 to 4000 g of total composition per hectare, and more commonly between 55 and 2000g/ha. The application is generally made by spraying the composition, typically by tractor mounted sprayer for large areas, but other methods such as dusting (for powders), drip ordrench can also be used.
The compositions ofthe invention can advantageously be used in the below-mentioned formulations (in which case active ingrédient relates to the respective mixture of compound of Formula (I) with a compound of component B or, when a safener is also used, the respective mixture ofthe compound of Formula (I) with the compound of component B and the safener).
The individual components ofthe composition ofthe invention may be utilised as the technical active ingrédient as produced. More typically however, the compositions according to the invention may be formulated in various ways using formulation adjuvants, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrâtes, microemulsifiable concentrâtes, oil-in-water émulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo-emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrâtes (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO and WHO Spécifications for Pesticides, United Nations, First Edition, Second Révision (2010). Such formulations can either be used directly or diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
The formulations can be prepared e.g. by mixing the active ingrédient with the formulation adjuvants in orderto obtain compositions in the form of finely divided solids, granules, solutions, dispersions or émulsions. The active ingrédients can also be formulated with other adjuvants, such as finely divided solids, minerai oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
The active ingrédients can also be contained in very fine microcapsules. Microcapsules contain the active ingrédients in a porous carrier. This enables the active ingrédients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually hâve a diameter of from 0.1 to 500 microns. They contain active ingrédients in an amount of about from 25 to 95 % by weight ofthe capsule weight. The active ingrédients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyuréthane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art. Alternatively, very fine microcapsules can be formed in which the active ingrédient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves encapsulated.
The formulation adjuvants that are suitable for the préparation ofthe compositions according to the invention are known perse. As liquid carriers there may be used: water, toluene, xylene, Petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylène carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, Λ/,/V-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobomyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, 10 methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phénol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, minerai oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, éthanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, /V-methyl-2-pyrrolidone and the like.
Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, 20 attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.
A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use.
Surface-active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents orsuspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate; soaps, such as sodium stéarate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stéarate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and di35 alkylphosphate esters; and also further substances described e.g. in McCutcheon's Détergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981).
Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, 40 corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers.
The formulations according to the invention can include an additive comprising an oil of vegetable or animal origin, a minerai oil, alkyl esters of such oils or mixtures of such oils and oil dérivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the mixture to be applied. For example, the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared. Preferred oil additives comprise minerai oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl dérivatives, or an oil of animal origin, such as fish oil or beef tallow. Preferred oil additives comprise alkyl esters of C8C22 fatty acids, especially the methyl dérivatives of C12-C18 fatty acids, for example 10 the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil dérivatives are known from the Compendium of Herbicide Adjuvants, 101h Edition, Southern Illinois University, 2010.
The formulations generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, of compounds (A) and (B) and from 1 to 99.9 % by weight of a formulation adjuvant which 15 preferably includes from 0 to 25 % by weight of a surface-active substance. Whereas commercial products may preferably be formulated as concentrâtes, the end user will normally employ dilute formulations.
The rates of application vary within wide limits and dépend on the nature ofthe soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and 20 other factors governed by the method of application, the time of application and the target crop. As a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to 1000 l/ha.
Preferred formulations can hâve the following compositions (weight %), wherein the term “active ingrédient” refers to the total weight % ofthe combination of ail active ingrédients in the 25 composition:
Emulsifiable concentrâtes:
active ingrédient: surface-active agent: liquid carrier: 30 Dusts: active ingrédient: solid carrier: Suspension concentrâtes: active ingrédient: 35 water: surface-active agent: 1 to 95 %, preferably 60 to 90 % 1 to 30 %, preferably 5 to 20 % 1 to 80 %, preferably 1 to 35 % 0.1 to 10 %, preferably 0.1 to 5 % 99.9 to 90 %, preferably 99.9 to 99 % 5 to 75 %, preferably 10 to 50 % 94 to 24 %, preferably 88 to 30 % 1 to 40 %, preferably 2 to 30 %
Wettable powders:
active ingrédient: 0.5 to 90 %, preferably 1 to 80 % surface-active agent: 0.5 to 20 %, preferably 1 to 15 % solid carrier: 5 to 95 %, preferably 15 to 90 %
Granules:
active ingrédient: 0.1 to 30 %, preferably 0.1 to 15 % solid carrier: 99.5 to 70 %, preferably 97 to 85 %
Various aspects and embodiments ofthe présent invention will now be illustrated in more detail by way of example. It will be appreciated that modification of detail may be made without departing from 10 the scope ofthe invention.
EXAMPLES
FORMULATION EXAMPLES
Wettable powders a) b) c)
active ingrédients 25% 50% 75%
sodium lignosulfonate 5% 5% -
sodium lauryl sulphate 3% - 5%
sodium diisobutylnaphthalenesulfonate - 6% 10%
phénol polyethylene glycol ether - 2% -
(7-8 mol of ethylene oxide)
highly dispersed silicic acid 5% 10% 10%
Kaolin 62% 27% -
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground 15 in a suitable mill, affording wettable powders that can be diluted with waterto give suspensions ofthe desired concentration.
Powders for dry seed treatment a) b) c)
active ingrédients 25% 50% 75%
light minerai oil 5% 5% 5%
highly dispersed silicic acid 5% 5% -
Kaolin 65% 40% -
Talcum - 20
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
Emulsifiable concentrate
active ingrédients 10%
octylphenol polyethylene glycol ether 3%
(4-5 mol of ethylene oxide)
calcium dodecylbenzenesulfonate 3%
castor oil polyglycol ether (35 mol of ethylene oxide) 4%
Cyclohexanone 30%
xylene mixture 50%
Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
Dusts a) b) C)
Active ingrédients 5% 6% 4%
Talcum 95% - -
Kaolin - 94% -
minerai filler - - 96%
Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
Extruded granules
Active ingrédients 15%
sodium lignosulfonate 2%
Carboxymethylcellulose 1 %
Kaolin 82%
The combination is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.
Coated granules
Active ingrédients 8%
polyethylene glycol (mol. wt. 200) 3%
Kaolin 89%
The finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
Suspension concentrate
active ingrédients 40%
propylene glycol 10%
nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6%
Sodium lignosulfonate 10%
Carboxymethylcellulose 1 %
silicone oil (in the form of a 75 % émulsion in water) 1 %
Water 32%
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Flowable concentrate for seed treatment
active ingrédients 40%
propylene glycol 5%
copolymer butanol PO/EO 2%
Tristyrenephenole with 10-20 moles EO 2%
1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 %
monoazo-pigment calcium sait 5%
Silicone oil (in the form of a 75 % émulsion in water) 0.2 %
Water 45.3 %
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected 5 against infestation by microorganisms, by spraying, pouring or immersion.
41
Tristyrenephenole with 10-20 moles EO 2%
1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 %
monoazo-pigment calcium sait 5%
Silicone oil (in the form of a 75 % émulsion in water) 0.2 %
Water 45.3 %
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected 5 against infestation by microorganisms, by spraying, pouring or immersion.
Slow Release Capsule Suspension
Parts ofthe combination are mixed with 2 parts of an aromatic solvent and 7 parts oftoluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture 10 of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this émulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% ofthe active ingrédients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
List of Abbreviations:
Boc = fert-butyloxycarbonyl br = broad
CDCh = chloroform-d
CDsOD = methanol-d °C = degrees Celsius
D2O = water-d
DCM = dichloromethane d = doublet dd = double doublet dt = double triplet
DMSO = dimethylsulfoxide
EtOAc = ethyl acetate h = hour(s)
HCl = hydrochloric acid
HPLC = high-performance liquid chromatography (description of the apparatus and the methods used for HPLC are given below) m = multiplet
M = molar min = minutes
MHz = mega hertz mL = millilitre mp = melting point ppm = parts per million q = quartet quin = quintet rt = room température s = singlet t = triplet
THF = tetrahydrofuran
LC/MS = Liquid Chromatography Mass Spectrometry
Préparative Reverse Phase HPLC Method:
Compounds purified by mass directed préparative HPLC using ES+/ES- on a Waters FractionLynx Autopurification system comprising a 2767 injector/collector with a 2545 gradient pump, two 515 isocratic pumps, SFO, 2998 photodiode array (Wavelength range (nm): 210 to 400), 2424 ELSD and QDa mass spectrometer. A Waters Atlantis T3 5micron 19x1 Omm guard column was used with a Waters
Atlantis T3 OBD, 5micron 30x100mm prep column.
Ionisation method: Electrospray positive and négative: Cône (V) 20.00, Source Température (°C) 120,
Cône Gas Flow (L/Hr.) 50
Mass range (Da): positive 100 to 800, négative 115 to 800.
The préparative HPLC was conducted using an 11.4 minute run time (not using at column dilution, 5 bypassed with the column selector), according to the following gradient table:
Time (mins) Solvent A (%) Solvent B (%) Flow (ml / min)
0.00 100 0 35
2.00 100 0 35
2.01 100 0 35
7.0 90 10 35
7.3 0 100 35
9.2 0 100 35
9.8 99 1 35
11.35 99 1 35
11.40 99 1 35
515 pump Oml/min Acetonitrile (ACD)
515 pump 1ml/min 90% Methanol/10% Water (make up pump)
Solvent A: Water with 0.05% Trifluoroacetic Acid
Solvent B: Acetonitrile with 0.05% Trifluoroacetic Acid
PREPARATION EXAMPLES FOR COMPOUNDS OF FORMULA (I)
EXAMPLE 1: Préparation of 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)ethanesulfonate (compound 1.001)
O
Step 1: Préparation of tributyl(pyridazin-4-yl)stannane
To a solution of lithium diisopropylamide (1M solution in tetrahydrofuran, 125 mL) at -78°C under nitrogen was added a solution of pyridazine (10g) and tri-n-butyltin chloride (44.6g) in THF (100 mL) drop wise. The reaction mixture was stirred at—78°C for 1 hour. The reaction mixture was warmed to room température and quenched with saturated aqueous ammonium chloride (100 mL) and extracted with ethyl acetate (3x150 mL). The organic layer was dried over sodium sulfate, concentrated and purified by chromatography on silica eluting with 30% ethyl acetate in hexanes to afford tributyl(pyridazin-4-yl)stannane as a pale brown liquid.
1H NMR (400MHz, CDCI3) 9.17 (t, 1H) 9.02 (dd, 1H) 7.54 (dd, 1H) 1.57-1.49 (m, 6H) 1.37-1.29 (m, 6H) 1.19-1.13 (m, 6H) 0.92-0.86 (m, 9H).
Step 2: Préparation of 2-pyridazin-4-ylpyrimidine
A solution of 2-bromopyrimidine (2.50g) and tributyl(pyridazin-4-yl)stannane (5.80g) in tetrahydrofuran (25 mL) was degassed with argon for 20 min. Tetrakis (triphenylphosphine) palladium 10 (0) (1,80g) was added to the reaction mixture at room température and then irradiated in a microwave at 120°C for 30 minutes. The reaction mixture was poured into water and extracted with ethyl acetate (100 mL). The organic layer was concentrated and purified by chromatography on silica eluting with 80% ethyl acetate in hexanes to give 2-pyridazin-4-ylpyrimidine as a beige solid.
1H NMR (400MHz, CDCI3) 10.17 (dd, 1H) 9.39 (dd, 1H) 8.92 (d, 2H) 8.43 (dd, 1H) 7.39 (t, 1H).
Step 3: Préparation of 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)ethanesulfonate (1.001)
A mixture of 2-pyridazin-4-ylpyrimidine (0.120g) and sodium 2-bromoethanesulfonate (0.196g) was stirred in water (2.3 mL) at 100°C for 42 hours. The reaction mixture was concentrated and purified by préparative reverse phase HPLC to give 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)ethanesulfonate as 20 a beige solid.
1HNMR (400MHz, D2O) 10.19 (d, 1H) 9.84 (d, 1H) 9.20 (dd, 1H) 8.99 (d, 2H) 7.64 (t, 1H) 5.27-5.18 (m, 2H) 3.71-3.63 (m, 2H).
EXAMPLE 2: Préparation of 4-pyridazin-4-ylpyrimidine
A microwave vial was charged with tributyl(pyridazin-4-yl)stannane (0.387g), 4-chloropyrimidine (0.100g), palladium (0) tetrakis(triphenylphosphine) (0.101g), césium fluoride (0.265g), cuprous iodide (0.00665g) and 1,4-dioxane (4.37 mL) and heated to 140°C under microwave conditions for 1 hour. The 30 reaction mixture was concentrated and purified by chromatography on silica eluting with a gradient from 0 to 70% acetonitrile in dichloromethane to give 4-pyridazin-4-ylpyrimidine as an orange solid.
1H NMR (400MHz, CDCh) 9.90-9.83 (m, 1H) 9.41 (dd,2H) 8.97 (d, 1H) 8.21-8.13 (m, 1H) 7.89 (dd, 1H).
EXAMPLE 3: Préparation of methyl 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)acetate bromide (compound 2.001)
Methyl bromoacetate (0.755g) was added drop wise to a solution of 2-pyridazin-4-ylpyrimidine (0.505g) in acetone (6.4mL) and heated at 60°C for 24 hours. The reaction mixture was concentrated and the residue triturated with dichloromethane. The resulting solid was filtered, washed with acetone and dried to give methyl 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)acetate bromide as a brown solid. 1HNMR (400MHz, D2O) 10.22 (d, 1 H) 9.84 (d, 1H) 9.30 (dd, 1H) 9.01 (d, 2H) 7.66 (t, 1H) 5.84 (s, 2H) 3.79 (s, 3H).
EXAMPLE 4: Préparation of (4-pyrimidin-2-ylpyridazin-1-ium-1-yl)methanesulfonate (compound 2.002)
O
Methyl 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)acetate bromide (0.420g) was stirred in trimethylsilyl chlorosulfonate (4.96g) at 80°C for 66 hours. The reaction mixture was carefully quenched with water, concentrated and purified by préparative reverse phase HPLC to give (4-pyrimidin-2ylpyridazin-1-ium-1-yl)methanesulfonate as a pale brown solid.
1H NMR (400MHz, D2O) 10.26 (brs, 1H) 9.94 (brd, 1H) 9.27-9.39 (m, 1H) 8.96-9.14 (m, 2H) 7.56-7.73 (m, 1H) 5.97 (s, 2H).
EXAMPLE 5: Préparation of 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1-sulfonate (compound 1.003)
To a solution of 2-pyridazin-4-ylpyrimidine (0.200g) in 1,4-dioxane (3.79mL) was added 1,3propanesultone (0.189g). The mixture was stirred at 90°C for 44 hours. The resulting solid was filtered off and washed with acetone. The solid was purified by préparative reverse phase HPLC to give 3-(420326 pyrimidin-2-ylpyridazin-1 -ium-1 -yl)propane-1 -sulfonate.
NMR (400MHz, D2O) 10.18 (d, 1H) 9.80 (d, 1H) 9.19 (dd, 1H) 9.00 (d, 2H) 7.64 (t, 1H) 5.01 (t, 2H) 2.98 (t, 2H) 2.53 (quin, 2H).
EXAMPLE 6: Préparation of 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2trifluoroacetate (compound 1.005)
Step 1: Préparation of 2-pyridazin-4-ylpyrazine
A mixture of tributyl(pyridazin-4-yl)stannane (3.87g), 2-chloropyrazine (1.00g), palladium (0) tetrakis(triphenylphosphine) (1.03g) and 1,4-dioxane (43.7 mL) was heated to 140°C under microwave conditions for 1 hour. The reaction mixture was concentrated and purified on silica using a gradient of 0% to 50% acetonitrile in dichloromethane to give 2-pyridazin-4-ylpyrazine as an off white solid.
1H NMR (400MHz, CDCb) 9.87 (dd, 1H) 9.39 (dd, 1H) 9.19 (d, 1H) 8.81-8.75 (m, 1H) 8.72 (d, 1H) 8.11 (dd, 1H).
Step 2: Préparation of methyl 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoate bromide
Methyl 3-bromopropanoate (0.518 mL) was added to a solution of 2-pyridazin-4-ylpyrazine (0.250g) in acetonitrile (15.8 mL). The reaction mixture was heated to 80°C for 24 hours. The reaction mixture was concentrated and the residue taken up in water and washed with dichloromethane. The aqueous phase was concentrated to give crude methyl 3-(4-pyrazin-2-ylpyridazin-1-ium-1yl)propanoate bromide (as a 1:1 mixture with 3-(5-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 25 bromide) as a brown gum, which was used crude in subséquent reactions.
Step 3: Préparation of 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2-trifluoroacetate (1.005)
The crude mixture of methyl 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoate bromide (0.515g) 30 and conc. hydrochioric acid (11.1 mL) was heated to 80°C for 4 hours. The reaction mixture was cooled and allowed to stand overnight. The reaction mixture was concentrated and purified by préparative reverse phase HPLC to give 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2-trifluoroacetate as a brown gum.
1H NMR (400MHz, CD3OD) 10.28 (d, 1H) 10.00 (d, 1H) 9.62 (d, 1H) 9.28 (dd, 1H) 8.96-8.93 (m, 1H)
8.90 (d, 1H) 5.19-5.12 (t, 2H) 3.28 (t, 2H).
EXAMPLE 7: Préparation of 2-(4-pyridazin-4-ylpyridazin-1-ium-1-yl)ethanesulfonate (compound 1.006)
O /
Step 1: Préparation of 2,2-dimethylpropyl 2-(2-tert-butoxycarbonyIhydrazino)ethanesulfonate
Boc-hydrazide (1.00g) was added to a solution of 2,2-dimethylpropyl ethenesulfonate (1.35g) in methanol (10.1 mL) and heated to 70°C for 24 hours. The reaction was concentrated to give 2,2dimethylpropyl 2-(2-tert-butoxycarbonylhydrazino)ethanesulfonate as a thick yellow liquid.
1H NMR (400MHz, CDCI3) 3.90 (s, 2H) 3.38-3.30 (m, 4H) 1.50-1.43 (s, 9H) 1.00-0.97 (s, 9H).
Step 2: Préparation of [2-(2,2-dimethylpropoxysulfonyl)ethylamino]ammonium chloride
A mixture of 2,2-dimethylpropyl 2-(2-tert-butoxycarbonylhydrazino)ethanesulfonate (1.00g) and 20 3M methanolic hydrogen chloride (24.2 mL) was heated to 70°C for 7 hours. The reaction mixture was concentrated to give [2-(2,2-dimethylpropoxysulfonyl)ethylamino]ammonium chloride as a pink gum that solidified on standing.
1H NMR (400MHz, CD3OD) 3.95 (s, 2H) 3.59-3.53 (m, 2H) 3.44-3.39 (m, 2H) 1.00 (s, 9H) sample contained ~20% methanol and was used as such.
Step 3: Préparation of 4-(3-furyl)pyridazine
To a mixture of 4-bromopyridazin-1-ium bromide (2.50g), sodium carbonate (2.2g), degassed toluene (17.3 mL) and 1,1'-bis(diphenylphosphino)ferrocenepalladium (II) dichloride (0.634g) was added a solution of 3-furylboronic acid (1.00g) in éthanol (17.3 mL). The mixture was heated to 80°C under nitrogen atmosphère for 24 hours. The reaction mixture was filtered through celite and concentrated. The residue was partitioned between water and dichloromethane then extracted with further dichloromethane. The combined organic layers were washed with brine and dried with magnésium sulfate. The concentrated filtrate was purified on silica eluting with a gradient of 0-100% ethyl acetate in iso-hexane to give 4-(3-furyl)pyridazine as a dark red semi-solid.
1H NMR (400 MHz, CD3OD) 9.45 (s, 1H) 9.03-9.16 (m, 1H) 8.36 (s, 1H) 7.86 (dd, 1 H) 7.71 (t, 1H) 7.04 (d, 1H).
Step 4: Préparation of 4-(2,5-dimethoxy-2,5-dihydrofuran-3-yl)pyridazine
A mixture of 4-(3-furyl)pyridazine (0.025g) and sodium bicarbonate (0.14g) in methanol (0.5 mL) was cooled to -10°C and bromine (0.069g) was added drop wise. After 30 minutes the reaction was quenched with 1:1 sat. aqueous sodium bicarbonate and 1M aqueous sodium thiosulfate (3 mL). The 15 aqueous layer was extracted with ethyl acetate. The organic layer was concentrated to give crude 4(2,5-dimethoxy-2,5-dihydrofuran-3-yl)pyridazine.
1H NMR (400 MHz, CD3OD) 9.42-9.41 (m, 1H) 9.20-9.19 (m, 1H) 7.85 (dt, 1H) 7.02-6.94 (m, 1H) 6.085.77 (m, 2H) 3.46 (d, 3H) 3.42 (d, 3H).
Step 5: Préparation of 2-(4-pyridazin-4-ylpyridazin-1-ium-1-yl)ethanesulfonate 1.006
A mixture of 4-(2,5-dimethoxy-2,5-dihydrofuran-3-yl)pyridazine (0.500g) and [2-(2,2dimethylpropoxysulfonyl)ethylamino]ammonium chloride (0.658g) was heated in aqueous 3M hydrochloric acid (12mL) at 60°C for 2 hours. The reaction mixture was concentrated and purified by préparative reverse phase HPLC to give 2-(4-pyridazin-4-ylpyridazin-1-ium-1-yl)ethanesulfonate as a 25 brown solid.
1H NMR (400MHz, D2O) 9.80-9.97 (m, 2H) 9.62-9.75 (m, 1H) 9.35-9.50 (m, 1H) 8.97 (dd, 1H) 8.19-8.42 (m, 1H) 5.20-5.29 (m, 2H) 3.59-3.73 (m, 2H).
EXAMPLE 8: Préparation of 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid chloride (compound 1.012)
A column packed with ion exchange resin (5.84g, Discovery DSC-SCX) was washed with water (3 column volumes). The 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2-trifluoroacetate (0.292g) dissolved in a minimum amount of water was loaded onto the column. The column was first eluted with water (3 column volumes) and then eluted with 2M hydrochloric acid (3 column volumes). The collected washings were concentrated to give 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid chloride as a yellow solid.
1H NMR (400MHz, D2O) 10.03 (d, 1H) 9.80 (d, 1H) 9.35 (d, 1H) 9.05 (dd, 1H) 8.87-8.82 (m, 1H) 8.76 (d, 1H) 5.08 (t, 2H) 3.22 (t, 2H).
EXAMPLE 9: Préparation of methyl 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoate chloride (compound 1.013)
A column packed with ion exchange resin (1.6g, Discovery DSC-SCX) was washed with methanol (3 column volumes). The 3-(4-pyrazin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2trifluoroacetate (0.081g) dissolved in a minimum amount of methanol was loaded onto the column. The column was first eluted with methanol (3 column volumes) and then eluted with 3M methanolic hydrochloric acid (3 column volumes). The collected washings were concentrated to give methyl 3-(4pyrazin-2-ylpyridazin-1-ium-1-yl)propanoate chloride as a blue gum.
1H NMR (400MHz, CD3OD) 10.30-10.26 (m, 1H) 10.04-10.00 (m, 1H) 9.66-9.64 (m, 1H) 9.33-9.30 (m, 1H) 8.97-8.93 (m, 1H) 8.91-8.88 (m, 1H) 5.25-5.14 (m, 2H) 3.71-3.68 (m, 3H) 3.35-3.27 (m, 2H).
EXAMPLE 10: Préparation of 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid bromide (compound 1.021)
A mixture of methyl 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoate 2,2,2-trifluoroacetate (0.2g), concentrated hydrogen bromide (1 mL, 48 mass%) and water (5 mL) was heated to 80°C for 4 hours and left to cool overnight. After a further 4 hours heating at 80°C the reaction mixture was concentrated and the resulting yellow gum was triturated with acetone to give 3-(4-pyrimidin-2ylpyridazin-1-ium-1-yl)propanoic acid bromide as a cream solid.
Ή NMR (400MHz, D2O) 10.16 (d, 1H) 9.86 (d, 1H) 9.21-9.15 (m, 1H) 8.99 (d, 2H) 7.64 (t, 1H) 5.11 (t, 2H) 3.24 (t, 2H).
EXAMPLE 11: Préparation of 1-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-2-sulfonate (compound 1.026)
Step 1 : Préparation of methyl 2-(2,2-dimethylpropoxysulfonyl)acetate
Methyl 2-chlorosulfonylacetate (0.5g) was added drop wise to a cooled (ice bath) solution of 2,2-dimethylpropan-1-ol (0.306g) and pyridine (0.284 mL) in dichloromethane (14.5 mL). The reaction mixture was stirred cold for a further 2 hours then partitioned with aqueous sat. ammonium chloride.
The aqueous phase was extracted with further dichloromethane (x2). The combined organic extracts were concentrated and passed through a plug of silica eluting with diethyl ether. The filtrate was concentrated to give methyl 2-(2,2-dimethylpropoxysulfonyl)acetate as a yellow liquid.
1H NMR (400MHz, CDCh) 4.11 (s, 2H) 4.00 (s, 2H) 3.84 (s, 3H) 1.01 (s, 9H).
Step 2: Préparation of methyl 2-(2,2-dimethylpropoxysulfonyl)propanoate
A mixture of sodium hydride (60% in minerai oil, 0.039g) in tetrahydrofuran (4.46 mL) was cooled (ice bath) to 0°C under nitrogen atmosphère. To this was added a solution of methyl 2-(2,220 dimethylpropoxysulfonyl)acetate (0.2g) in tetrahydrofuran (1.78 mL) and stirred at this température for 5 minutes, lodomethane (0.067 mL) was added and the reaction was allowed to warm to room température and stirred for 1 hour. The reaction mixture was partitioned between 2M hydrochloric acid and ethyl acetate. The aqueous layer was extracted with further ethyl acetate (x2). The combined organic extracts were dried with magnésium sulfate and concentrated to give methyl 2-(2,225 dimethylpropoxysulfonyl)propanoate as a yellow liquid.
1H NMR (400MHz, CDCh) 4.12-4.09 (m, 1H) 3.97 (d, 2H) 3.83 (s, 3H) 1.69 (d, 3H) 0.99 (s, 9H).
Step 3: Préparation of 2,2-dimethylpropyl 1-hydroxypropane-2-sulfonate
To a cooled (ice bath) solution of methyl 2-(2,2-dimethylpropoxysulfonyl)propanoate (1g) in dichloromethane (126 mL) was added dropwise, under nitrogen atmosphère, diisobutylaluminum hydride (1M in dichloromethane, 10.5 mL) maintaining the température below 5°C during the addition. The reaction mixture was stirred at 0°C for 1 hour. Propan-2-ol (12.6 mL) was added and the reaction mixture was stirred at 0°C for 1 hour and then allowed to warm to room température. The reaction mixture was partitioned between 2M aqueous hydrochloric acid and dichloromethane. The organic phase was dried with magnésium sulfate, concentrated and chromatographed on silica using a gradient from 0 to 100% EtOAc in isohexane to give 2,2-dimethylpropyl 1-hydroxypropane-2-sulfonate as a colourless liquid.
1H NMR (400MHz, CDCh) 4.03-3.84 (m, 4H) 3.43-3.33 (m, 1 H) 2.60-2.52 (m, 1 H) 1.45 (d, 3H) 1.00 (s, 9H).
Step 4: Préparation of 1-hydroxypropane-2-sulfonic acid
A mixture of 2,2-dimethylpropyl 1-hydroxypropane-2-sulfonate (0.25g) and 6M aqueous hydrochloric acid (9.51 mL) was heated to 95°C for 4 hours. The reaction mixture was cooled and concentrated by freeze drying.
1H NMR (400MHz, D2O) 3.88-3.78 (m, 1H) 3.56-3.47 (m, 1H) 2.98-2.89 (m, 1 H) 1.18 (d, 3H).
Step 5: Préparation of 1-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-2-sulfonate 1.026
To a cooled (ice bath) solution of 2-pyridazin-4-ylpyrimidine (0.1g) in dry acetonitrile (6.32 mL) was added 1,1,1-trifluoro-N-(trifluoromethylsulfonyl)methanesulfonamide (0.131 mL) and the reaction mixture was stirred at room température for 15 minutes. To this mixture was added triphenylphosphine (0.332g) and a solution of 1-hydroxypropane-2-sulfonic acid (0.133g) in acetonitrile (0.5mL), followed by drop wise addition of diisopropyl azodicarboxylate (0.25 mL). The reaction mixture was heated at 80°C for 170 hours. The reaction mixture was concentrated and partitioned between water and diethyl ether. The aqueous layer was concentrated and purified by préparative reverse phase HPLC to givel(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-2-sulfonate as a white solid.
1H NMR (400MHz, D2O) 10.20-10.18 (m, 1H) 9.81 (dd, 1H) 9.19 (dd, 1H) 9.00 (d, 2H) 7.65 (t, 1H) 5.105.07 (m, 2H) 3.84-3.74 (m, 1H) 1.39 (d, 3H).
EXAMPLE 12: Préparation of 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butanoic acid 2,2,2trifluoroacetate (compound 2.003)
To a mixture of 2-pyridazin-4-ylpyrimidine (0.5g) in water (10 mL) was added but-2-enoic acid (0.816g). The mixture was heated at reflux for 40 hours. The reaction mixture was concentrated and the resulting solid was triturated with tert-butylmethylether and acetone. The solid was purified by préparative reverse phase HPLC to give 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butanoic acid 2,2,2trifluoroacetate.
i 'H NMR (400MHz, D2O) 10.22 (d, 1H) 9.92 (d, 1H) 9.18-9.26 (m, 1H) 8.99-9.05 (m, 2H) 7.68 (t, 1H) 5.49-5.60 (m, 1 H) 3.39 (dd, 1 H) 3.10-3.21 (m, 1 H) 1.71 (d, 3H).
EXAMPLE 13: Préparation of 3-bromo-N-methylsulfonyl-propanamide
To a solution of methanesulfonamide (0.5g) in toluene (25.8 mL) was added 3-bromopropionyl chloride (1,77g) drop wise at room température. The reaction mixture was heated at 110°C for 4 hours. The reaction was cooled in ice and the resulting solid was filtered and washed with cold toluene to give 3-bromo-/V-methylsulfonyl-propanamide as a colourless solid.
1H NMR (400MHz, CDCh) 8.28 (brs, 1H) 3.62 (t, 2H) 3.34 (s, 3H) 2.94 (t, 2H).
EXAMPLE 14: Préparation of 2-hydroxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1sulfonate (compound 2.004)
O
A mixture of 2-pyridazin-4-ylpyrimidine (0.3g), water (6 mL) and sodium 3-chloro-2-hydroxypropane-1-sulfonate (0.45g) was heated at reflux for 3 days. The reaction mixture was concentrated and the resulting solid was washed with Abutylmethyl ether and acetone. The solid was purified by préparative reverse phase HPLC to give 2-hydroxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1sulfonate, 2.004.
1H NMR (400MHz, D2O) 10.24 (d, 1H) 9.80 (d, 1H) 9.25 (dd, 1H) 9.04 (d, 2H) 7.68 (t, 1H) 5.21 (dd, 1H)
4.93 (dd, 1H) 4.64-4.71 (m, 1H) 3.19-3.36 (m, 2H).
EXAMPLE 15: Préparation of 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,25 trifluoroacetate (compound 1.023) A125
3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid chloride (0.119g) was stirred in 2,2,2trifluoroacetic acid (4 mL) at room température for two hours. The reaction mixture was concentrated and freeze dried to give 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2-trifluoroacetate, 10 A125, as a pale yellow gum, which solidified on standing.
1H NMR (400MHz, D2O) 10.18-10.13 (m, 1H) 9.87-9.82 (m, 1H) 9.20-9.14 (m, 1H) 8.98 (d, 2H) 7.63 (s, 1H) 5.10 (s, 2H) 3.24 (t, 2H).
EXAMPLE 16: Préparation of 3-methyl-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butanoic acid
2,2,2-trifluoroacetate (compound 1.025)
OH F
A mixture of 2-pyridazin-4-ylpyrimidine (1g), 3,3-dimethylacrylic acid (1.96g), 2,2,2trifluoroacetic acid (5 mL) and water (5 mL) was heated at 100°C under microwave conditions for 18 20 hours. The reaction mixture was concentrated and the resulting solid was washed with diethyl ether (5x10 mL). The solid was purified by preparative reverse phase HPLC to give 3-methyl-3-(4-pyrimidin2-ylpyridazin-1 -ium-1 -yl)butanoic acid 2,2,2-trifluoroacetate, 1.025.
1H NMR (400MHz, D2O) 10.18 (m, 1H) 9.97 (m, 1H) 9.21 (m, 1H) 8.98 (m, 2H) 7.61 (m, 1H) 3.36 (s, 2H) 1.94 (S, 6H).
EXAMPLE 17: Préparation of 3-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)propanoic acid chloride (compound 1.027)
O
Step 1 : Préparation of 3-pyridazin-4-ylpyridazine
A microwave vial, under nitrogen atmosphère, was charged with tributyl(pyridazin-4-yl)stannane (0.697g), 3-bromopyridazine (0.25g), palladium (0) tetrakis(triphenylphosphine) (0.185g) and 1,4dioxane (7.86 mL) and heated at 140°C in the microwave for 1 hour. The reaction mixture was concentrated and purified on silica using a gradient of 0% to 50% acetonitrile in dichloromethane to give 3-pyridazin-4-ylpyridazine as an orange solid.
1H NMR (400MHz, CDCh) 9.94-9.89 (m, 1H) 9.42 (dd, 1H) 9.35 (dd, 1H) 8.24 (dd, 1H) 8.09 (dd, 1H) 7.79-7.72 (m, 1H).
Step 2: Préparation of 3-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2trifluoroacetate (compound 2.005)
A mixture of 3-pyridazin-4-ylpyridazine (0.25g), water (15 mL) and 3-bromopropanoic acid (0.363g) was heated at 100°C for 25 hours. The mixture was concentrated and purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give 3-(4-pyridazin-3-ylpyridazin-1ium-1-yl)propanoic acid 2,2,2-trifluoroacetate, 2.005.
1H NMR (400MHz, D2O) 10.11 (d, 1H) 9.88 (d, 1H) 9.32 (dd, 1H) 9.10 (dd, 1H) 8.50 (dd, 1H) 7.99 (dd, 1H) 5.13 (t, 2H) 3.26 (t, 2H) (one CO2H proton missing).
Step 3: Préparation of 3-(4-pyridazin-1-ium-3-ylpyridazin-1-ium-1-yl)propanoic acid dichloride (compound 1.034)
A mixture of 3-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)propanoic acid 2,2,2-trifluoroacetate (6.56g) and 2M aqueous hydrochloric acid (114 mL) was stirred at room température for 3 hours. The mixture was concentrated and the residue was taken up in a small amount of water and freeze dried. The resulting glassy yellow solid was stirred in acetone (105 mL) ovemight. The solid material was collected by filtration, washed with further acetone and dried under vacuum to give 3-(4-pyridazin-1-ium-320326 ylpyridazin-1-ium-1-yl)propanoic acid dichloride, 1.034, as a beige solid.
1H NMR (400MHz, D2O) 10.11 (d, 1H) 9.88 (d, 1H) 9.36 (brd, 1H) 9.10 (dd, 1 H) 8.48-8.56 (m, 1H) 7.928.07 (m, 1H) 4.98-5.20 (m, 2H) 3.18-3.32 (m, 2H) (one CO2H proton missing)
Step 4: Préparation of 3-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)propanoic acid chloride (compound 1.027)
A mixture of 3-(4-pyridazin-1-ium-3-ylpyridazin-1-ium-1-yl)propanoic acid dichloride (0.541g) and 2-propanol (10 mL) was heated at 90°C. Water was added drop wise until a clear solution was obtained, this took ~0.8 mL. To this was added further hot 2-propanol (10 mL) and the solution left to cool. Filtered off the precipitate and washed with cold 2-propanol and acetone and dried under vacuum to give 3-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)propanoic acid chloride, 1.027, as a beige solid.
1H NMR (400 MHz, D2O) 10.11 (d, 1H) 9.87 (d, 1H) 9.32 (dd, 1H) 9.12-9.08 (m, 1H) 8.50 (dd, 1H) 7.99 (dd, 1 H) 5.12 (t, 2H) 3.24 (t, 2H) (one CO2H proton missing)
EXAMPLE 18: Préparation of 2-(4-pyridazin-1-ium-3-ylpyridazin-1-ium-1-yl)ethanesulfonate chloride (compound 1.031)
Step 1: Préparation of 2-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)ethanesulfonate (compound 1.002)
A mixture of 3-pyridazin-4-ylpyridazine (0.41g), sodium 2-bromoethanesulfonic acid (0.656g) and water (7.78 mL) was heated at 100°C for 17 hours. The reaction mixture was cooled, filtered through a syringe filter and purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the 25 eluent) to give 2-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)ethanesulfonate as a yellow solid.
1H NMR (400MHz, D2O) 10.15 (d, 1H) 9.87 (d, 1 H) 9.33 (dd, 1H) 9.12 (dd, 1H) 8.52 (dd, 1H) 7.99 (dd, 1H) 5.32-5.19 (m, 2H) 3.73-3.65 (m, 2H)
Step 2: Préparation of 2-(4-pyridazin-1-ium-3-ylpyridazin-1-ium-1-yl)ethanesulfonate chloride 5 (compound 1.031)
A solution of 2-(4-pyridazin-3-ylpyridazin-1-ium-1-yl)ethanesulfonate (0.2g) and 2M aqueous hydrochloric acid (5 mL) was stirred at room température for 2 hours. The mixture was concentrated and the residue was taken up in a small amount of water and freeze dried to give 2-(4-pyridazin-1-ium3-ylpyridazin-1-ium-1-yl)ethanesulfonate chloride as a cream glass like solid.
1H NMR (400MHz, D2O) 10.13 (d, 1H) 9.86 (d, 1H) 9.35 (dd, 1H) 9.11 (dd, 1H) 8.57 (dd, 1H) 8.05 (dd, 1H) 5.27-5.21 (m, 2H) 3.71-3.64 (m, 2H) (one NH proton missing)
EXAMPLE 19: Préparation of 4-pyridazin-4-ylpyrimidin-2-amine
A microwave vial, under nitrogen atmosphère, was charged with tributyl(pyridazin-4-yl)stannane (3.42g), 4-pyridazin-4-ylpyrimidin-2-amine (0.727g), palladium (0) tetrakis(triphenylphosphine) (0.892g), Λ/,/V-diisopropylethylamine (1.35 mL) and 1,4-dioxane (38.6 mL) and heated to 140°C in the microwave for 1 hour. The reaction mixture was concentrated and purified on silica using a gradient of 0% to 70% 20 acetonitrile in dichloromethane to give 4-pyridazin-4-ylpyrimidin-2-amine as a beige solid.
1H NMR (400MHz, de-DMSO) 9.82 (dd, 1H) 9.41 (dd, 1H) 8.47 (d, 1H) 8.22 (dd, 1H) 7.38 (d, 1H) 6.98 (br s, 2H)
EXAMPLE 20: Préparation of 2-methyl-2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1sulfonate (compound 2.006)
Step 1: Préparation of 2,2-dimethylpropyl methanesulfonate
A solution of triethylamine (8.1 mL) and 2,2-dimethylpropan-1-ol (2.3g) in dichloromethane (40 mL) was cooled to 0°C in an ice/acetone bath. To this was added methanesulfonyl chloride (2.2 mL) drop wise. The reaction mixture was stirred cold for 2 hours and washed with aqueous ammonium chloride. The organic layer was concentrated and the residue dissolved in ether. The ether solution was passed through a plug of silica eluting with further ether. Concentration ofthe ether filtrate gave 2,2dimethylpropyl methanesulfonate as a light yellow liquid.
1H NMR (400MHz, CDCb) 3.90-3.85 (m, 2H) 3.01 (s, 3H) 1.00 (s, 9H)
Step 2: Préparation of 2,2-dimethylpropyl 2-hydroxy-2-methyl-propane-1-sulfonate
A solution of 2,2-dimethylpropyl methanesulfonate (1.75g) in tetrahydrofuran (22.1 mL) was cooled to -78°C under nitrogen atmosphère. Tothis was added drop wise n-butyllithium (2.5 mol/L in hexane, 5.1 mL). The reaction mixture was gradually warmed to -30°C over 2 hours and acetone (7.73 mL) was added. The reaction mixture was warmed to room température and stirred for a further 1.5 hours. The reaction was quenched with 2M aqueous hydrochloric acid and extracted with ethyl acetate (x3). The combined organic extracts were dried with magnésium sulfate, concentrated and purified on silica using a gradient from 0 to 100% ethyl acetate in iso-hexane to give 2,2-dimethylpropyl 2-hydroxy2-methyl-propane-1-sulfonate as a colourless liquid.
1H NMR (400MHz, CDCb) 3.90 (s, 2H) 3.32 (s, 2H) 2.79 (brs, 1H) 1.44 (s, 6H) 0.99 (s, 9H)
Step 3: Préparation of 2-hydroxy-2-methyl-propane-1-sulfonic acid
I o \\ OH —Y X
HO O
A mixture of 2,2-dimethylpropyl 2-hydroxy-2-methyl-propane-1-sulfonate (1.84g) and 6M aqueous hydrochloric acid (32.8 mL) was heated at 95°C for 4 hours. The reaction mixture was cooled to room température and freeze dried overnightto give 2-hydroxy-2-methyl-propane-1-sulfonic acid as an off white solid.
1H NMR (400 MHz, D2O) 2.99 (s, 2H) 1.24 (s, 6H) (one OH proton and one SO3H proton missing)
Step 4: Préparation of 2-methyl-2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1-sulfonate (2.006)
A mixture of 2-pyridazin-4-ylpyrimidine (0.507g) in dry acetonitrile (32.1 mL) was cooled in an ice bath. To this was added 1,1,1-trifluoro-N-(trifluoromethylsulfonyl)methanesulfonamide (0.663 mL) 5 and the reaction mixture stirred at room température for 15 minutes. To this was added triphenylphosphine (1.68g) and a solution of2-hydroxy-2-methyl-propane-1-sulfonic acid (0.741g) in dry acetonitrile (0.5 mL) followed by drop wise addition of diisopropyl azodicarboxylate (1.26 mL, 1.30 g). The reaction mixture was then heated at 80°C for 144 hours. The reaction mixture was partitioned between water and dichloromethane and the aqueous layer purified by préparative reverse phase HPLC 10 (trifluoroacetic acid is présent in the eluent) to give 2-methyl-2-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propane-1-sulfonate as a yellow solid.
1H NMR (400MHz, CD3OD) 10.41-10.35 (m, 1H) 10.05-9.99 (m, 1H) 9.31 (dd, 1H) 9.12 (d, 2H) 7.67 (t,
H) 3.67 (s, 2H)2.10(s, 6H)
EXAMPLE 21: Préparation of 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1-sulfonate (compound 2.007)
Step 1: Préparation of 2,2-dimethylpropyl 2-hydroxypropane-1-sulfonate
A solution of 2,2-dimethylpropyl methanesulfonate (2g) in tetrahydrofuran (25 mL) was cooled to -78°C under nitrogen atmosphère and n-butyllithium (2.5 mol/L in hexane, 5.8 mL) was added drop wise. The reaction mixture was gradually warmed to -30°C over 1 hour and acetaldehyde (6.8 mL) was 25 added.
The reaction mixture was warmed to room température and stirred for a further 2.5 hours. The reaction was quenched with 2M aqueous hydrochloric acid and extracted with ethyl acetate (x3). The combined organic extracts were dried with magnésium sulfate, concentrated and purified on silica using a gradient from 0 to 100% ethyl acetate in iso-hexane to give 2,2-dimethylpropyl 2-hydroxypropane-130 sulfonate as a yellow liquid.
1H NMR (400MHz, CDCh) 4.47-4.34 (m, 1H) 3.96-3.87 (m, 2H) 3.25-3.17 (m, 2H) 3.01 (brs, 1H) 1.34 (d, 3H) 1.00 (s, 9H)
Step 2: Préparation of 2-hydroxypropane-1-sulfonic acid
A mixture of 2,2-dimethylpropyl 2-hydroxypropane-1-sulfonate (1.35g) and 6M aqueous hydrochloric acid (32.8 mL) was heated at 95°C for 4 hours. The reaction mixture was cooled to room température and freeze dried overnight to give 2-hydroxypropane-1-sulfonic acid as a brown solid.
1H NMR (400 MHz, D2O) 4.17-4.06 (m, 1H) 2.99-2.85 (m, 2H) 1.16 (d, 3H) (one OH proton and one SO3H proton missing)
Step 3: Préparation of 2-(trifluoromethylsulfonyloxy)propane-1 -sulfonic acid
To a mixture of 2-hydroxypropane-1-sulfonic acid (0.2g) in dichloromethane (2.57 mL) was added 2,6-dimethylpyridine (0.33 mL) and the resulting mixture was cooled to 0°C. To this was added drop wise trifluoromethylsulfonyl trifluoromethanesulfonate (0.264 mL) and stirring continued at this température for 15 minutes. Cooling was removed and the reaction mixture was stirred at room température for a further hour. The reaction mixture was quenched with water and extracted with dichloromethane (x3). The combined organic extracts were dried with magnésium sulfate and concentrated to give 2-(trifluoromethylsulfonyloxy)propane-1-sulfonic acid as a brown gum, ~50% purity. The product was used immediately in subséquent reactions without further purification.
1H NMR (400MHz, CDCI3) product peaks only 5.57-5.41 (m, 1H) 4.18-3.98 (m, 1H) 3.58-3.35 (m, 1H) 1.76-1.65 (m, 3H) (one SO3H proton missing)
Step 4: Préparation of 2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propane-1-sulfonate 2.007
A mixture of 2-pyridazin-4-ylpyrimidine (0.15g), 2-(trifluoromethylsulfonyloxy)propane-1sulfonate (0.55g) and 1,4-dioxane (7.8 mL) was heated at 90°C for 24 hours. The reaction mixture was partitioned between water and dichloromethane and the aqueous layer purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give 2-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propane-1-sulfonate as a yellow solid.
1H NMR (400MHz, CD3OD) 10.43-10.37 (m, 1H) 9.93 (dd, 1H) 9.34 (dd, 1H) 9.11 (d, 2H) 7.68 (t, 1H) 5.66-5.53 (m, 1H) 3.66 (dd, 1H) 3.43 (dd, 1H) 1.83 (d, 3H)
EXAMPLE 22: Préparation of [(1S)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propyl]ammonium 2,2,2-trifluoroacetate (compound 1.035)
Step 1: Préparation of [(1S)-3-bromo-1-methoxycarbonyl-propyl]ammonium chloride
O
To a mixture of (2S)-2-amino-4-bromo-butanoicacid (0.2g) in dry methanol (4 mL) at 0°C, under nitrogen atmosphère, was added thionyl chloride (0.392g) drop wise. The reaction mixture was stirred overnight at room température and concentrated to give crude [(1S)-3-bromo-1-methoxycarbonylpropyl]ammonium chloride as an orange gum, which was used without further purification.
Step 2: Préparation of methyl (2S)-2-(benzyIoxycarbonylamino)-4-bromo-butanoate
Crude [(1S)-3-bromo-1-methoxycarbonyl-propyl]ammonium chloride was stirred in dichloromethane (4 mL) and a solution of sodium hydrogen carbonate (0.28g) in water (4 mL) was added. The mixture was cooled to 0°C and benzyl carbonochloridate (0.225g) was added. The reaction mass was warmed to room température and stirred for 15 hours. The reaction mixture was diluted with water (10 mL) and extracted with dichloromethane (3x20 mL). The combined organic layers were dried over sodium sulfate, concentrated and purified on silica using a gradient from 0 to 100% ethyl acetate in cyclohexane to give methyl (2S)-2-(benzyloxycarbonylamino)-4-bromo-butanoate.
1H NMR (400MHz, CDCh) 7.30-7.40 (m, 5H) 5.37-5.43 (m, 1 H) 5.13 (s, 2H) 3.78 (s, 3H) 3.42-3.46 (m, 2H) 2.25-2.49 (m, 2H)
Step 3: Préparation of methyl (2S)-2-(benzyloxycarbonylamino)-4-(4-pyrimidin-2-ylpyridazin-1ium-1 -yl)butanoate iodide
To a solution of methyl (2S)-2-(benzyloxycarbonylamino)-4-bromo-butanoate (0.1g) in dry acetone (2 mL), under nitrogen atmosphère, was added sodium iodide (0.054g). The reaction mixture was stirred at room température overnight. To this was added 2-pyridazin-4-ylpyrimidine (0.048g) and the mixture heated at reflux for 16 hours. The reaction mixture was concentrated and the crude methyl (2S)-2-(benzyloxycarbonylamino)-4-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butanoate iodide was used in the next step without further purification.
Step 4: Préparation of [(1S)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propyl]ammonium 2,2,2-trifluoroacetate 1.035
A mixture of methyl (2S)-2-(benzyloxycarbonylamino)-4-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)butanoate iodide (0.5g) and concentrated hydrochloric acid (4.9 mL) was heated at 80°C for 30 minutes. The reaction mixture was concentrated, dissolved in water and extracted with ethyl acetate (3x20 mL). The aqueous layer was purified by preparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give [(1S)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propyl]ammonium 2,2,2-trifluoroacetate.
1H NMR (400 MHz, D2O) 10.26 (d, 1H) 9.90 (d, 1H) 9.27 (dd, 1H) 9.06 (d, 2H) 7.72 (t, 1H) 5.17 (t, 2H) 4.09 (dd, 1H) 2.76-2.79 (m, 2H) (Three NH protons and one CO2H proton missing)
EXAMPLE 23: Préparation of [(1R)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propyl]ammonium 2,2,2-trifluoroacetate (compound 1.029)
Step 1: Préparation of [(1R)-3-bromo-1-methoxycarbonyl-propyl]ammonium chloride
To a mixture of [(1 R)-3-bromo-1-carboxy-propyl]ammonium bromide (0.1g) in dry methanol (2 mL) at 0°C, under nitrogen atmosphère, was added thionyl chloride (0.083 mL) drop wise. The reaction mixture was stirred ovemight at room température and concentrated to give crude [(1S)-3-bromo-110 methoxycarbonyl-propyl]ammonium chloride as a yellow solid, which was used without further purification.
Step 2: Préparation of [(1R)-1-methoxycarbonyl-3-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propyl]ammonium bromide chloride
To a mixture of 2-pyridazin-4-ylpyrimidine (0.1g) in acetonitrile (3.16 mL) was added [(1R)-3bromo-1-methoxycarbonyl-propyl]ammonium chloride (0.16g) The mixture was heated at reflux for 12 hours. The reaction mixture was concentrated to give crude [(1R)-1-methoxycarbonyl-3-(4-pyrimidin-2ylpyridazin-1-ium-1-yl)propyl]ammonium bromide as a dark brown gum, which was used without further 20 purification.
Step 3: Préparation of [(1R)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propyl]ammonium 2,2,2-trifluoroacetate, 1.029
A mixture of [(1 R)-1-methoxycarbonyl-3-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propyl]ammonium bromide (0.5g) and 2M aqueous hydrochloric acid (7.29 mL) was heated at 80°C for 2 hours. The reaction mixture was concentrated and purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give [(1R)-1-carboxy-3-(4-pyrimidin-2-ylpyridazin-1-ium1-yl)propyl]ammonium 2,2,2-trifluoroacetate.
1H NMR (400 MHz, D2O) 10.22 (s, 1H) 9.87 (d, 1H) 9.24 (d, 1H) 8.99-9.04 (m, 2H) 7.66 (t, 1H) 5.16 (t, 2H) 4.17 (dd, 1H) 2.69-2.85 (m, 2H) (Three NH protons and one CO2H proton missing)
EXAMPLE 24: Préparation of [(1S)-1-carboxy-2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)ethyl]ammonium 2,2,2-trifluoroacetate (compound 2.009)
Step 1: Préparation of (2S)-2-(tert-butoxycarbonylamino)-3-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propanoate
To a mixture of 2-pyridazin-4-ylpyrimidine (0.05g) in dry acetonitrile (1 mL) was added tert-butyl N-[(3S)-2-oxooxetan-3-yl]carbamate (0.071g) and the reaction mixture was stirred at room température 20 for 48 hours. Concentration ofthe reaction mixture gave crude (2S)-2-(tert-butoxycarbonylamino)-3-(4pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoate, which was used without further purification.
Step 2: Préparation of [(1S)-1-carboxy-2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)ethyl]ammonium 2,2,2-trifluoroacetate, 2.009 25 A mixture of (2S)-2-(tert-butoxycarbonylamino)-3-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propanoate (0.4g) and 2M aqueous hydrochloric acid (10 mL) was stirred at room température for 18 hours. The reaction mixture was concentrated and purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give [(1S)-1-carboxy-2-(4-pyrimidin-2-ylpyridazin-1-ium1 -yl)ethyl]ammonium 2,2,2-trifluoroacetate.
1H NMR (400 MHz, D2O) 10.26 (s, 1H) 9.94 (d, 1H) 9.31-9.34 (m, 1H) 9.04 (dd, 2H) 7.69 (t, 1H) 5.48 5 (d, 2H) 4.75 (t, 1 H) (Three NH protons and one CO2H proton missing)
EXAMPLE 25: Préparation of dimethylsulfamoyl-[2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)acetyl]azanide (compound 1.032)
Step 1 : Préparation of 2-bromo-A/-(dimethylsulfamoyl)acetamide
H
To a solution of dimethylsulfamide (0.5g) and 4-(dimethylamino)pyridine (0.541g) in dichloromethane (19.9 mL) at 0°C was added bromoacetyl bromide (0.903g) drop wise. The reaction 15 was slowly warmed to room température and stirred for 24 hours. The reaction was partitioned with 0.5M aqueous hydrochioric acid. The organic layer was dried over magnésium sulfate and concentrated to give crude 2-bromo-N-(dimethylsulfamoyl)acetamide as a pale yellow oil. The product was used without further purification.
Step 2: Préparation of dimethylsulfamoyl-[2-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)acetyl]azanide 1.032
To a solution of 2-pyridazin-4-ylpyrimidine (0.15g) in acetonitrile (10 mL) was added 2-bromo/V-(dimethylsulfamoyl)acetamide (0.21g) and the mixture heated at 80°C for 16 hours. The resulting precipitate was filtered, washed with acetonitrile (2x20 mL) to give dimethylsulfamoyl-[2-(4-pyrimidin-225 ylpyridazin-1-ium-1-yl)acetyl]azanide as a light green solid.
1H NMR (400 MHz, ds-DMSO) 10.36 (s, 1H) 10.06-10.10 (m, 1H) 9.56-9.62 (m, 1H) 9.18-9.22 (m, 2H)
7.82-7.86 (m, 1H) 5.88-5.94 (m, 2H) 2.80-2.86 (m, 6H)
EXAMPLE 26: Préparation of 3-bromo-N-cyano-propanamide
To a stirred solution of cyanamide (0.5g) in water (10 mL) and tetrahydrofuran (10 mL) at 0°C was added sodium hydroxide (1.427g). After 10 minutes at 0°C a solution of 3-bromopropanoyl chloride (1.27 mL) in tetrahydrofuran (5 mL) was added drop wise. The resulting reaction mixture was stirred at room température for 3 hours. Water was added and the mixture was extracted with dichloromethane (2x75 mL). The combined organic layers were dried over sodium sulfate and concentrated to give 3bromo-/V-cyano-propanamide as a light yellow liquid.
1H NMR (400 MHz, de-DMSO) 12.40 (brs, 1H) 3.54-3.70 (m, 2H) 2.80-2.94 (m, 2H)
EXAMPLE 27: Préparation of [(1S)-1-carboxy-4-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butyl]ammonium dichloride (compound 1.030)
Step 1: Préparation of dimethyl (2S)-2-[bis(tert-butoxycarbonyl)amino]pentanedioate
To a solution of dimethyl (2S)-2-(tert-butoxycarbonylamino)pentanedioate (0.3g) in acetonitrile (6 mL), under nitrogen atmosphère, was added 4-dimethylaminopyridine (0.028g). The mixture was cooled to 0°C and di-terf-butyl dicarbonate (0.264g) was added. The reaction was allowed to warm to room température and stirred for 18 hours. The reaction mixture was partitioned between water and ethyl acetate (80 mL) and extracted with further ethyl acetate (80 mL). The combined organic layers were washed with 10% aqueous citric acid, followed by saturated sodium bicarbonate solution and brine.
The combined organic layers were dried over sodium sulfate, concentrated and purified on silica using ethyl acetate in cyclohexane to give dimethyl (2S)-2-[bis(tert-butoxycarbonyl)amino]pentanedioate as a colourless gum.
1H NMR (400MHz, CDCb) 4.95 (dd, 1H) 3.73 (s, 3H) 3.68 (s, 3H) 2.36-2.54 (m, 3H) 2.15-2.23 (m, 1H)
1.50 (s, 18H)
Step 2: Préparation of methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-oxo-pentanoate
Cooled a solution of dimethyl (2S)-2-[bis(tert-butoxycarbonyl)amino]pentanedioate (0.28g) in diethyl ether (5.6 mL), under nitrogen atmosphère, to -78°C and added slowly diisobutylaluminum hydride (1M in Toluene, 0.82 mL). The reaction was stirred at-78°C for 10 minutes, then quenched with water (0.094 mL) and stirred for a further 30 minutes. After warming to room température solid sodium sulfate was added. The mixture was filtered through Celite, washed with fert-butylmethylether and the filtrate concentrated to give methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-oxo-pentanoate.
1H NMR (400MHz, CDCb) 9.78 (s, 1H)4.90 (dd, 1H) 3.73 (m, 3H) 2.45-2.66 (m, 3H) 2.11-2.28 (m, 1H) 1.42-1.63 (m, 18H)
Step 3: Préparation of methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-hydroxy-pentanoate
Cooled a solution of methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-oxo-pentanoate (0.2g) in dry methanol (4 mL), under nitrogen atmosphère, to 0°C and added sodium borohydride (0.025g) portion wise and stirred for 2 hours. The reaction mixture was concentrated and purified on silica using ethyl acetate in cyclohexane to give methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-hydroxy-pentanoate as a colourless gum.
1H NMR (400MHz, CDCb) 4.90 (dd, 1 H) 3.74-3.67 (m, 5H) 2.30-2.20 (m, 1 H) 1.99-1.89 (m, 1 H) 1.681.41 (s, 20H) (one OH proton missing)
Step 4: Préparation of methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-bromo-pentanoate
Cooled a solution of methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-hydroxy-pentanoate (4g) in dry tetrahydrofuran (40 mL) to 0°C and added carbon tetrabromide (5.728g). To this was added drop wise a solution of triphenylphosphine (4.576g) in tetrahydrofuran (40 mL). The reaction was allowed to warm to room température and stirred for 24 hours. The reaction mixture was concentrated and purified on silica using ethyl acetate in cyclohexane to give methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5bromo-pentanoate.
1H NMR (400MHz, CDCb) 4.88 (dd, 1H) 3.73 (s, 3H) 3.38-3.50 (m, 2H) 2.24-2.27 (m, 1H) 1.85-2.12 (m, 3H) 1.51 (s, 18H)
Step 5: Préparation of [(1S)-1-methoxycarbonyl-4-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)butyl]ammonium 2,2,2-trifluoroacetate
To a mixture of 2-pyridazin-4-ylpyrimidine (0.4g) in acetonitrile (12.6 mL) was added methyl (2S)-2-[bis(tert-butoxycarbonyl)amino]-5-bromo-pentanoate (1.141g) and the reaction mixture was heated at reflux for 12 hours. The reaction mixture was concentrated and purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent which led to the loss ofthe BOC-protecting groups) to give [(1S)-1-methoxycarbonyl-4-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butyl]ammonium 2,2,2trifluoroacetate.
1H NMR (400 MHz, D2O) 10.22 (d, 1H) 9.80-9.86 (m, 1H) 9.20-9.27 (m, 1H) 8.99-9.06 (m, 2H) 7.667.73 (m, 1H) 4.90-5.01 (m, 2H) 4.20 (t, 1H) 3.76-3.84 (m, 3H) 2.20-2.40 (m, 2H) 1.97-2.18 (m, 2H) (NH protons are missing)
Step 6: Préparation of [(1S)-1-carboxy-4-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)butyl]ammonium dichlonde, 1.030
A mixture of [(1S)-1-methoxycarbonyl-4-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)butyl]ammonium;2,2,2-trifluoroacetate (0.1g) and 4M aqueous hydrochloric acid (0.78 mL) was heated at 60°C for 14 hours. The reaction mixture was concentrated to give [(1S)-1-carboxy-4-(4pyrimidin-2-ylpyridazin-1-ium-1-yl)butyl]ammonium dichloride.
1H NMR (400 MHz, D2O) 10.24 (dd, 1H) 9.87 (dd, 1H) 9.27 (dd, 1H) 9.06 (d, 2H) 7.72 (t, 1H) 4.99 (t, 2H) 4.08 (t, 1 H) 2.23-2.44 (m, 2H) 2.00-2.16 (m, 2H) (three NH protons and one CO2H proton missing)
EXAMPLE 28: Préparation of 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid chloride (compound 1.010)
Step 1: Préparation of methyl 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoate 2,2,2trifluoroacetate (compound 2.011)
A mixture of methyl 3-bromopropanoate (1.58g), 2-pyridazin-4-ylpyrimidine (0.5g) in acetonitrile (31.6 mL) was heated at 80°C for 24 hours. The reaction mixture was cooled, concentrated and partitioned between water (10 mL) and dichloromethane (20 mL). The aqueous layer was purified by préparative reverse phase HPLC (trifluoroacetic acid is présent in the eluent) to give methyl 3-(4pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoate 2,2,2-trifluoroacetate as an orange gum.
1H NMR (400MHz, D2O) 10.15 (d, 1H) 9.85 (d, 1H) 9.18 (dd, 1H) 8.98 (d, 2H) 7.63 (t, 1H) 5.12 (t, 2H) 3.59 (s, 3H) 3.25 (t, 2H) 4 H NMR (400MHz, CD3OD) 10.43-10.32 (m, 1H) 10.04 (d, 1H) 9.43 (dd, 1H) 9.12 (d, 2H) 7.65 (t, 1H) 5.18 (t, 2H) 3.70 (s, 3H) 3.36-3.27 (m, 2H)
Step 2: 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoic acid chloride, 1.010
A mixture of methyl 3-(4-pyrimidin-2-ylpyridazin-1-ium-1-yl)propanoate;2,2,2-trifluoroacetate (0.392g) and conc. hydrochloric acid (7.66 mL) was heated at 80°C for 3 hours. The reaction mixture was cooled, concentrated and triturated with acetone to give 3-(4-pyrimidin-2-ylpyridazin-1-ium-1yl)propanoic acid çhloride as a beige solid.
1H NMR (400MHz, D2O) 10.16 (d, 1H) 9.85 (d, 1H) 9.18 (dd, 1H) 8.99 (d, 2H) 7.64 (t, 1H) 5.11 (t, 2H) 3.24 (t, 2H) (one CO2H proton missing)
Additional compounds in Table A (below) were prepared by analogues procedures, from appropriate starting materials. The skilled person would understand that the compounds of Formula (I) may exist as an agronomically acceptable sait, a zwitterion or an agronomically acceptable sait of a zwitterion as described hereinbefore. Where mentioned the spécifie counterion is not considered to be 10 limiting, and the compound of Formula (I) may be formed with any suitable counter ion.
NMR spectra contained herein were recorded on either a 400MHz Bruker AVANCE III HD equipped with a Bruker SMART probe unless otherwise stated. Chemical shifts are expressed as ppm downfield from TMS, with an internai reference of either TMS or the residual solvent signais. The following multiplicities are used to describe the peaks: s = singlet, d = doublet, t = triplet, dd = double 15 doublet, dt = double triplet, q = quartet, quin = quintet, m = multiplet. Additionally br. is used to describe a broad signal and app. is used to describe and apparent multiplicity.
Compounds 1.001, 1.002, 1.003, 1.004, 1.005, 1.006, 1.007, 1.008, 1.009, 1.010, 1.011, 1.012, 1.013, 1.014, 1.015, 1.016, 1.017, 1.018, 1.019, 1.020, 1.021, 1.022, 1.023, 1.024, 1.025, 20 1.026, 1.027, 1.028, 1.029, 1.030, 1.031, 1.032, 1.033, 1.034 and 1.035 were prepared using the general methods as described above, or in an analagous manner. Table A below shows the structure of these compounds and NMR characterising data.
Table A Préparation Examples of compounds of Formula (I)
Compound No. Structure 1H NMR
1.001 Οχ /° / 0 ô 0 (400MHz, D2O) 10.19 (d, 1H) 9.84 (d, 1H) 9.20 (dd, 1H) 8.99 (d, 2H) 7.64 (t, 1H) 5.27-5.18 (m, 2H) 3.71-3.63 (m, 2H)
1.002 z--> / \ Z A // z. A w / z--' # o 0 I (400MHz, D2O) 10.15 (d, 1H) 9.87 (d, 1H) 9.33 (dd, 1H) 9.12 (dd, 1H) 8.52 (dd, 1H) 7.99 (dd,1H) 5.32-5.19 (m, 2H) 3.73-3.65 (m, 2H)
1.003 p z X \ / z=/ ζθ o I 0 (400MHz, D2O) 10.18 (d, 1H) 9.80 (d, 1H) 9.19 (dd, 1H) 9.00 (d, 2H) 7.64 (t, 1H) 5.01 (t, 2H) 2.98 (t, 2H) 2.53 (quin, 2H)
Compound No. Structure 1H NMR
1.004 Y l1+ OH o / Il G X S. \A - A0 >r o 0 F I F (400MHz, D2O) 10.08 (d, 1H) 9.79 (d, 1H) 9.39 (d, 1H) 9.08 (dd, 1H) 8.89-8.83 (m, 1 H) 8.78 (d, 1H) 5.24-5.16 (t, 2H) 3.65 (t, 2H)
1.005 X o Γ ô / ° z^z (400MHz, CD3OD) 10.28 (d, 1H) 10.00 (d, 1H) 9.62 (d, 1 H) 9.28 (dd, 1 H) 8.96-8.93 (m, 1 H) 8.90 (d, 1H) 5.19-5.12 (t, 2H) 3.28 (t, 2H) (one CO2H proton missing)
1.006 O o< // / o y-------- I r=z / \ 4 z (400MHz, D2O) 9.80-9.97 (m, 2H) 9.62-9.75 (m, 1H) 9.35-9.50 (m, 1H) 8.97 (dd, 1H) 8.19-8.42 (m, 1H) 5.20-5.29 (m, 2H) 3.59-3.73 (m, 2H)
1.007 z / y--Z V 'ύ z ') t \ / O z=/ \ / + \=o Οχ / Tl T| f/ O ' (400MHz, D2O) 9.86-9.95 (m, 2H) 8.90-9.00 (m, 3H) 8.35 (brd, 2H) 5.27 (t, 2H) 3.69 (t, 2H) (one N H proton missing)
1.008 nh2 îS O ll+ o Y A g // F JL ^G \G 'c TA O ❖ XOH FX| O F (400 MHz, D2O) 10.11 (d, 1H) 9.96 (d, 1H) 9.13 (dd, 1H) 8.29 (d, 1H) 6.83 (d, 1H) 5.31 (m, 2H) 3.73(m, 2H) (Two NH2 protons and one SO3H proton missing)
1.009 I O A / ωχ __/ SO z=z r (400 MHz, D2O) 10.22 (d, 1H) 9.86 (d, 1H) 9.21 (dd, 1H) 8.90 (s, 2H) 5.25-5.31 (m, 2H) 3.69-3.77 (m, 2H) 2.44 (s, 3H)
Compound No. Structure Ή NMR
1.010 O cl L N/ j OH (400 MHz, D20) 10.16 (d, 1H) 9.85 (d, 1H) 9.18 (dd, 1H) 8.99 (d, 2H) 7.64 (t, 1 H) 5.11 (t, 2H) 3.24 (t, 2H) (one CO2H proton missing)
1.011 I ! ô o x V—o /=2 / \ G Z y /“€ \ z z=/ (400MHz, CD3OD) 10.32 (d, 1H) 10.13 (d, 1H) 9.56 (s, 1H) 9.42-9.35 (m, 1H) 9.23 (d, 1H) 8.61 (d, 1H) 5.21 (t, 2H) 3.32-3.27 (m, 2H) (one CO2H proton missing)
1.012 Op IL .n) oh JJ O or (400MHz, D2O) 10.03 (d, 1H) 9.80 (d, 1H) 9.35 (d, 1H) 9.05 (dd, 1H) 8.87-8.82 (m, 1H) 8.76 (d, 1H) 5.08 (t, 2H) 3.22 (t, 2H) (one CO2H proton missing)
1.013 A IL A/ .o JJ O (400MHz, CD3OD) 10.30-10.26 (m, 1H) 10.0410.00 (m, 1H) 9.66-9.64 (m, 1H) 9.33-9.30 (m, 1H) 8.97-8.93 (m, 1H) 8.91-8.88 (m, 1H) 5.255.14 (m, 2H) 3.71-3.68 (m, 3H) 3.35-3.27 (m, 2H)
1.014 1 O °x // ωχ z—z c=/ y=z (400MHz, D2O) 10.12 (d, 1H) 9.83 (d, 1H) 9.08 (dd, 1H) 8.42 (d, 1H) 7.89 (d, 1H) 5.28-5.19 (m, 2H) 3.71-3.64 (m, 2H) 2.74 (s, 3H)
1.015 (S IL Wy o (400MHz, D2O) 10.20 (d, 1H) 9.91 (d, 1H) 9.22 (dd, 1H) 8.86 (d, 1H) 7.58 (d, 1 H) 5.18 (t, 2H) 3.31 (t, 2H) 2.66 (s, 3H)
Compound No. Structure Ή NMR
1.016 nh2 (S L oh o [f Il o f. JL F I F (400 MHz, D20) 10.06 (s, 1H) 10.00 (d, 1 H) 9.13 (dd, 1H) 8.28 (d, 1H) 6.85 (d, 1H) 5.20 (t, 2H) 3.31 (t, 2H) (Two NH2 protons and one CO2H proton missing)
1.017 ll+ X/N\/N^0 O (400 MHz, D2O) 10.09 (d, 1H) 9.81 (d, 1H) 9.10 (m, 1H) 7.37 (s, 1H) 5.08 (t, 2H) 3.21 (t, 2H) 2.51 (s, 6H)
1.018 ΓΧ n N O Il r I o fI F (400MHz, CD3OD) 10.21-10.34 (m, 1H) 9.97 (d, 1H) 9.25-9.35 (m, 1H) 9.10-9.15 (m, 2H) 7.607.76 (m, 1 H) 7.16-7.34 (m, 5H) 5.16-5.24 (m, 2H) 5.05-5.15 (m, 2H) 3.31-3.39 (m, 2H)
1.019 O O W/ θ=ω r—H C / z=/ (400MHz, CD3OD) 10.24-10.20 (m, 1H) 9.93 (d, 1H) 9.24 (dd, 1H) 9.02 (d, 1H) 7.89 (d, 1H) 5.11 (t, 2H) 4.11 (s, 3H) 2.93 (t, 2H) 2.61 (quin, 2H)
1.020 q o y A N f>t ° ° F (400MHz, CD3OD) 10.35-10.47 (m, 1H) 10.05 (d, 1H) 9.37-9.44 (m, 1H) 9.08-9.15 (m, 2H) 7.657.78 (m, 1H) 7.32-7.43 (m, 2H) 7.18-7.27 (m, 1H) 7.03-7.15 (m, 2H) 5.30 (t, 2H) 3.58 (t, 2H)
1.021 N (T\ L Y OH Y Br- 0 (400MHz, D2O) 10.16 (d, 1H) 9.86 (d, 1H) 9.219.15 (m, 1H) 8.99 (d, 2H) 7.64 (t, 1H) 5.11 (t, 2H) 3.24 (t, 2H) (one CO2H proton missing)
Compound No. Structure Ή NMR
1.022 N V o L /N* JL foH Il fr Xx y A ^F II o A< 0 I F F (400MHz, D2O) 10.16 (d, 1H) 9.79 (d, 1H) 9.20 (dd, 1 H) 9.00 (d, 2H) 7.64 (t, 1 H) 5.04 (s, 2H) 1.25 (s, 6H) (one CO2H proton missing)
1.023 Cu 0 U N* .OH Yx F. JL >r ° o F I F (400MHz, D2O) 10.18-10.13 (m, 1H) 9.87-9.82 (m, 1H) 9.20-9.14 (m, 1H) 8.98 (d, 2H) 7.63 (s, 1H) 5.10 (s, 2H) 3.24 (t, 2H) (one CO2H proton missing)
1.024 F j U^OH fY ° 0 F (400MHz, D2O) 10.16-10.25 (m, 1H) 9.81-9.89 (m, 1H) 9.19-9.27 (m, 1H) 8.97-9.09 (m, 2H) 7.63-7.74 (m, 1H) 5.08-5.20 (m, 1H) 4.92-5.01 (m, 1H) 3.35-3.47 (m, 1H) 1.31 (d, 3H) (one CO2H proton missing)
1.025 ^''hr'Y^Y 0 ll+ Il UxNLxYxOH R JL if 4 °~ A S F (400 MHz, D2O) 10.18 (m, 1H) 9.97 (m, 1H) 9.21 (m, 1H) 8.98 (m, 2H) 7.61 (m, 1H) 3.36 (s, 2H) 1.94 (s, 6H) (one CO2H proton missing)
1.026 Ou N 11 i I l + o IL /N7 JL / Yx 0«-° (400MHz, D2O) 10.20-10.18 (m, 1H) 9.81 (dd, 1 H) 9.19 (dd, 1H) 9.00 (d, 2H), 7.65 (t, 1H) 5.105.07 (m, 2H) 3.84-3.74 (m, 1H) 1.39 (d, 3H)
1.027 4 2 y—z f o (400 MHz, D2O) 10.11 (d, 1H) 9.87 (d, 1H) 9.32 (dd, 1H) 9.12-9.08 (m, 1H) 8.50 (dd, 1H) 7.99 (dd, 1H) 5.12 (t, 2H) 3.24 (t, 2H) (one CO2H proton missing)
1.028 'o \ ..o : z=z Q (400 MHz, D2O) 10.24 (d, 1H) 9.80 (d, 1H) 9.25 (dd, 1H) 9.04 (d, 2H) 7.68 (t, 1H) 5.21 (dd, 1H) 4.93 (dd, 1H) 4.64-4.71 (m, 1H) 3.19-3.36 (m, 2H) (one OH proton missing)
Compound No. Structure 1H NMR
1.029 o n || 1 F oh ll+ 1 o M M Il F JL = o“ nhÎ fY F (400 MHz, D2O) 10.22 (s, 1H) 9.87 (d, 1H) 9.24 (d, 1H) 8.99-9.04 (m, 2H) 7.66 (t, 1H) 5.16 (t, 2H) 4.17 (dd, 1H) 2.69-2.85 (m, 2H) (Three NH protons and one CO2H proton missing)
1.030 L AL _ Hc> .O τγ ci n+ Γ cr L. AK (400MHz, D2O) 10.24 (dd, 1H) 9.87 (dd, 1H) 9.27 (dd, 1H) 9.06 (d, 2H) 7.72 (t, 1H) 4.99 (t, 2H) 4.08 (t, 1H) 2.23-2.44 (m, 2H) 2.00-2.16 (m, 2H) (three NH protons and one CO2H proton missing)
1.031 cr |i j jL AL z\ rr 7^ η II + o A A< ❖ o ° (400 MHz, D2O) 10.13 (d, 1H) 9.86 (d, 1H) 9.35 (dd, 1 H) 9.11 (dd, 1H) 8.57 (dd, 1H) 8.05 (dd, 1 H) 5.27-5.21 (m, 2H) 3.71-3.64 (m, 2H) (one NH proton missing)
1.032 o 1 W χω O'' * i r=z / \ G z y / (400 MHz, ds-DMSO) 10.36 (s, 1H) 10.06-10.10 (m, 1H) 9.56-9.62 (m, 1H) 9.18-9.22 (m, 2H) 7.82-7.86 (m, 1 H) 5.88-5.94 (m, 2H) 2.80-2.86 (m, 6H)
1.033 A^n Il N n Y >X a- O (400 MHz, D2O) 10.16 (s, 1H) 9.86 (d, 1H) 9.169.20 (m, 1H) 8.96-9.02 (m, 2H) 7.60-7.66 (m, 1H) 5.08-5.14 (m, 2H) 3.20-3.28 (m, 2H)
1.034 H 1 + N Cl S ^N ( A ΜΑΆα^ν ll + NCl’ 0 (400MHz, D2O) 10.11 (d, 1H) 9.88 (d, 1H) 9.36 (brd, 1H) 9.10 (dd, 1H)8.48-8.56 (m, 1H) 7.928.07 (m, 1 H) 4.98-5.20 (m, 2H) 3.18-3.32 (m, 2H) (one CO2H proton missing)
1.035 Tl “Π /=° 9 \ ° C) z=z Z—< \ i \ >=o “+ Λ—° / V i q o 1 (400 MHz, D2O) 10.26 (d, 1H) 9.90 (d, 1H) 9.27 (dd, 1H) 9.06 (d, 2H) 7.72 (t, 1H) 5.17 (t, 2H) 4.09 (dd, 1H) 2.76-2.79 (m, 2H) (Three NH protons and one CO2H proton missing)
BIOLOGICAL EFFICACY FOR COMPOUNDS OF FORMULA (I)
B1 Post-emergence efficacy
Seeds of a variety of test species were sown in standard laom-based soil in pots:- Ipomoea hederacea (IPOHE), Euphorbia heterophylla (EPHHL), Chenopodium album (CHEAL), Amaranthus 5 palmeri (ΑΜΑΡΑ), Lolium perenne (LOLPE), Digitaria sanguinalis (DIGSA), Eleusine indice (ELEIN), Echinochloa crus-galli (ECHCG), Setaria faberi (SETFA), . After cultivation for 14 days (postemergence) under controlled conditions in a glasshouse (at 24/16 °C, day/night; 14 hours light; 65 % humidity), the plants were sprayed with an aqueous spray solution derived from the dissolution ofthe technical active ingrédient Formula (I) in a small amount of acetone and a spécial solvent and emulsifier 10 mixture referred to as IF50 (11.12% Emulsogen EL360 TM + 44.44% N-methylpyrrolidone + 44.44% Dowanol DPM glycol ether), to create a 50g/l solution which was then diluted to required concentration using 0.25% or 1% Empicol ESC70 (Sodium lauryl ether sulphate) + 1% ammonium sulphate as diluent. The delivery of the aqueous spray solution was via a laboratory track sprayer which delivered the aqueous spray composition at a rate of 200 litres per hectare, using a fiat fan nozzle (Teejet 11002VS) 15 and an application volume of 200litre/ha (at2 bar).
The test plants were then grown in a glasshouse under controlled conditions (at 24/16 °C, day/night; 14 hours light; 65 % humidity) and watered twice daily. After 13 days the test was evaluated (100 = total damage to plant; 0 = no damage to plant).
The results are shown in Table B (below). A value of n/a indicates that this combination of weed 20 and test compound was not tested/assessed.
Table B Control of weed species by compounds of Formula (I) after post-emergence application
Compound Number Application Rate g/Ha ΑΜΑΡΑ CHEAL EPHHL IPOHE SETFA ECHCG ELEIN DIGSA LU Q. _J O _l
1.001 500 100 100 100 100 100 70 100 100 70
1.002 500 100 100 100 40 90 100 100 100 100
1.003 500 100 100 100 60 100 80 100 100 60
1.004 500 100 100 100 60 90 80 100 100 60
1.005 500 100 100 70 30 60 100 100 100 80
1.006 500 100 100 100 100 30 60 100 80 80
1.007 500 100 100 40 30 70 80 100 100 90
1.008 500 n/a 100 80 40 100 100 100 100 60
1.009 500 n/a 100 70 30 100 100 100 100 80
1.010 500 n/a 100 100 40 100 100 100 100 90
1.011 500 100 100 100 100 100 90 100 90 70
1.012 500 100 100 100 20 90 90 90 100 50
1.013 500 100 90 100 80 100 80 100 100 70
1.014 500 100 100 100 n/a 100 80 90 100 90
1.015 500 n/a 100 80 30 100 100 100 100 80
1.016 500 n/a 90 90 30 100 100 100 100 70
1.017 500 n/a 100 80 50 100 70 100 100 60
1.018 500 90 90 100 30 100 80 100 100 40
1.019 500 n/a 100 100 60 100 70 90 100 30
1.020 500 100 80 80 30 100 90 100 100 80
1.021 500 100 100 100 100 100 100 100 100 70
1.022 500 100 80 100 100 100 90 100 100 60
Compound Number Application Rate g/Ha ΑΜΑΡΑ CHEAL EPHHL IPOHE SETFA ECHCG ELEIN DIGSA LOLPE
1.023 500 100 80 100 30 100 100 100 100 90
1.024 500 100 90 100 40 100 100 100 90 80
1.025 500 100 70 40 50 100 100 100 90 30
1.026 500 100 80 90 70 100 80 100 100 80
1.027 500 100 100 100 30 100 100 80 100 100
1.028 500 100 90 80 30 100 100 100 90 70
1.029 500 100 100 90 90 100 60 100 90 20
1.030 500 100 100 100 60 100 100 90 100 60
1.031 500 100 90 100 70 100 100 100 100 90
1.032 500 100 100 100 40 90 100 100 100 80
1.033 500 100 100 100 50 90 90 100 100 90
1.034 500 100 100 100 60 100 100 100 100 90
1.035 500 100 100 90 90 100 60 100 90 20
BIOLOGICAL EFFICACY FOR COMBINATIONS OF THE INVENTION
Using the methodology described above under B1, the efficacy of various combinations ofthe 5 invention were tested against plants selected from the following species: Ipomoea hederacea (IPOHE), Euphorbia heterophylla (EPHHL), Chenopodium album (CHEAL), Amaranthus palmeri (ΑΜΑΡΑ), Lolium perenne (LOLPE), Digitaria sanguinalis (DIGSA), Eleusine indica (ELEIN), Echinochloa crusgalli (ECHCG), Setaria faberi (SETFA), Triticum aestivum (TRZAW), Portulaca oleracea (POROL), Digitaria horizontalis (DIGHO), Lolium multiflorum (LOLMU), Conyza canadensis (ERICA), Conyza 10 bonariensis (ERIBO), Alopecurus myosuroides (ALOMY). After 21 days the tests were evaluated (100 = total damage to plant; 0 = no damage to plant), and the results are shown below in tables B2.1 to B2.21.
Table B2.1 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and ________________glufosinate as component (B)_______________________________________________________________
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B ZEAMX TRZAW POROL SETFA LOLMU
C1 125 250 1:2 37 40 97 72 67
C2 250 250 1:1 33 53 93 73 72
C3 500 250 2:1 50 78 100 90 75
Table B2.2 Herbicidal activity of a compound glufosinate as component (B) I of Formul; 3 (I) (compound 1.002) as component (A) and
Composition Component Component Ratio DIGSA CHEAL ΑΜΑΡΑ IPOHE
ID no. (A) (g/Ha) (B) (g/Ha) A: B
C4 50 200 1:4 95 92 98 77
C5 100 200 1:2 88 93 93 69
C6 200 200 1:1 95 97 100 83
C7 400 200 2:1 87 98 100 91
Table B2.3 Herbicidal activity of a compound of Formula (I) (compound 1.001) glyphosate as component (B) as component (A) and
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B ZEAMX TRZAW POROL SETFA LOLMU
C8 C9 C10 125 250 500 500 500 500 1:4 1:2 1:1 52 70 80 83 92 80 92 99 100 93 72 91 75 93 78
5 Table B2.4 Herbicidal activity of a compound of Formula (I) (compound 1.002) glyphosate as component (B) as component (A) and
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B DIGSA CHEAL ΑΜΑΡΑ IPOHE
C11 C12 C13 C14 50 100 200 400 200 200 200 200 1:4 1:2 1:1 2:1 93 90 96 96 77 80 88 91 96 98 98 98 53 57 58 60
10 Table B2.5 Herbicidal activity of a compound of Formula (1) (compound 1.001) hydantocidin as component (B) as component (A) and
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B ZEAMX TRZAW POROL SETFA LOLMU
C15 C16 C17 125 250 500 250 250 250 1:2 1:1 2:1 38 40 40 52 68 70 100 100 100 70 82 75 77 83 80
Table B2.6 15 ___________ Composition ID no. Herbicidal activity of a compound of Formula (I) (compound 1.001) < is component (A) and diquat as
component (B) LOLPE ECHCG
Component (A) (g/Ha) Component (B) (g/Ha) Ratio A:B IPOHE ERICA ΑΜΑΡΑ
C18 50 100 1:2 80 83 25 100 83
C19 100 100 1:1 100 75 25 100 92
C20 200 100 2:1 100 97 25 100 77
C21 400 100 4:1 100 97 88 100 90
Table B2.7 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and diquat as _______________component (B)_______________________________________________________________________
Composition Component Component Ratio ZEAMX TRZAW POROL SETFA LOLMU ID no.(A) (g/Ha) (B) (g/Ha) A: B
C22 125 150 1:2 38 81 100 47 95
C23 250 150 1:1 38 86 100 58 95
C24 500 150 2:1 53 90 100 57 94
Table B2.8 Herbicidal activity of a compound of Formula (I) (compound 1.002) as component (A) and diquat as
component (B)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A:B IPOHE LOLPE ECHCG ERICA ΑΜΑΡΑ
C25 50 100 1:2 95 85 35 100 78
C26 100 100 1:1 100 95 40 100 90
C27 200 100 2:1 100 91 40 100 87
C28 400 100 4:1 100 99 69 100 92
Table B2.9 Herbicidal activity of a compound of Formula (I) (compound 1.010) as component (A) and diquat as _______________component (B)________________________________________________________________________
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A:B IPOHE ELEIN LOLPE ECHCG ERICA ΑΜΑΡΑ
C29 50 100 1:2 100 93 88 96 100 100
C30 100 100 1:1 100 83 97 94 100 100
C31 200 100 2:1 100 40 78 98 100 100
C32 400 100 4:1 100 50 85 94 100 100
5 Table B2.10 Herbicidal activity of a compound of Formula (I) (compound 1.027) as component (A) and diquat as component (B)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B IPOHE ELEIN LOLPE ECHCG ERICA ΑΜΑΡΑ
C33 50 100 1:2 100 83 96 95 100 100
C34 100 100 1:1 100 75 97 100 100 100
C35 200 100 2:1 100 70 97 95 100 100
C36 400 100 4:1 100 60 97 98 100 100
Table B2.11
Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and saflufenacil as component (B)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B ERICA ERIBO
C37 50 25 2:1 100 98
C38 100 25 4:1 100 100
C39 200 25 8:1 100 100
C40 400 25 16:1 100 100
Table B2.12 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and fomesafen
as component (B)
Composition Component Component Ratio IPOHE ELEIN LOLPE ECHCG ERICA ΑΜΑΡΑ
ID no. (A) (g/Ha) (B) (g/Ha) A: B
C41 50 200 1:4 100 88 78 83 100 100
C42 100 200 1:2 100 88 73 90 100 100
C43 200 200 1:1 100 90 80 83 100 100
C44 400 200 2:1 99 83 80 78 100 100
Table B2.13 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and fomesafen
as component (B)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A:B ZEAMX TRZAW POROL DIGHO SETFA LOLMU ERIBO
C45 75 200 3:8 17 40 99 75 48 25 40
C46 150 200 3:4 17 57 99 83 62 33 68
C47 300 200 3:2 18 70 98 97 84 53 89
Table B2.14 20 Herbicidal activity of a compound of Formula (I) (compound 1.002) as component (A) and fomesafen as component (B)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A:B ZEAMX TRZAW POROL DIGHO SETFA LOLMU ERIBO
C48 75 200 3:8 22 33 98 55 97 53 50
C49 150 200 3:4 22 58 98 75 87 77 67
C50_______ 300 200 3:2 25 75 98 66 88 88 75
79
Table B2.15 Herbicidal activity of a compound of Formula (1) (compound 1.001) as component (A) and oxyfluorfen as component (B)
Composition Component Component Ratio ZEAMX TRZAW DIGHO SETFA LOLMU ERICA ERIBO
ID no. (A) (g/Ha) (B) (g/Ha) A:B
C51 100 100 1:1 62 87 97 99 87 100 77
C52 400 100 4:1 58 95 97 99 96 100 90
C53 800 100 8:1 68 98 99 99 96 100 94
Table B2.16 Herbicidal activity of a compound of Formula (I) (compound 1.002) as component (A) and
5 oxyfluorfen as component (B)
Composition Component Component Ratio ZEAMX TRZAW DIGHO SETFA LOLMU ERICA ERIBO
ID no. (A) (g/Ha) (B) (g/Ha) A:B
C54 100 100 1:1 48 92 97 98 97 100 80
C55 400 100 4:1 43 95 95 97 98 100 91
C56 800 100 8:1 72 97 98 99 99 100 100
Table B2.17 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and atrazine
as component (B)
Composition Component Component Ratio IPOHE ELEIN LOLPE ECHCG ERICA ΑΜΑΡΑ
ID no. (A) (g/Ha) (B) (g/Ha) A:B
C57 50 150 1:3 25 95 88 100 100 93
C58 100 150 2:3 50 96 88 100 100 100
C59 200 150 4:3 70 98 95 100 100 98
C60 400 150 8:3 73 96 96 100 100 100
C61 50 300 1:6 73 95 98 100 100 100
C62 100 300 1:3 78 95 98 100 100 100
C63 200 300 2:3 83 98 98 100 100 100
C64 400 300 4:3 85 97 98 100 100 100
10 Table B2.18 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and atrazine
as component (B)
Composition Component Component Ratio ZEAMX TRZAW POROL DIGHO SETFA LOLMU ERIBO
ID no. (A) (g/Ha) (B) (g/Ha) A:B
C65 75 250 3:10 17 20 99 63 86 88 62
C66 150 250 3:5 17 22 99 65 77 98 72
C67 300 250 6:5 28 50 100 73 85 98 88
Table B2.19 Herbicidal activity of a compound of Formula (1) (compound 1.002) as component (A) and atrazine
as component (B)
Composition Component Component Ratio ZEAMX TRZAW POROL DIGHO SETFA LOLMU ERIBO
ID no. (A) (g/Ha) (B) (g/Ha) A:B
C68 75 250 3:10 20 67 100 88 98 98 82
C69 150 250 3:5 22 81 100 95 98 98 86
C70 300 250 6:5 27 94 100 100 98 98 93
15
Table B2.20 Herbicidal activity of a compound of Formula (I) (compound 1.002) as component (A) and atrazine
as component (B)
Composition Component Component Ratio DIGSA CHEAL ΑΜΑΡΑ IPOHE
ID no. (A) (g/Ha) (B) (g/Ha) A: B
C71 50 250 1:5 96 98 100 27
C72 100 250 2:5 96 98 100 30
C73 200 250 4:5 98 98 100 40
C74 400__________250__________8:5 96_________99_________100 38
Table B2.21 Herbicidal activity of a compound of Formula (I) (compound 1.001) as component (A) and metribuzin as component (B)
Composition Component Component Ratio IPOHE ELEIN LOLPE ECHCG ERICA ΑΜΑΡΑ
ID no. (A) (g/Ha) (B) (g/Ha) A: B
C75 50 140 5:14 96 98 100 100 100 15
C76 100 140 5:7 96 96 100 100 100 15
C77 200 140 10:7 96 98 100 100 100 18
C78 400 140 20:7 94 97 100 100 100 20
5
Table B2.22a Herbicidal activity against IPOHE of a compound of Formula (1) (compound 1.010) as component
__(A) and compuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula)
Composition Component Component Ratio IPOHE
ID no. (A) (g/Ha) (B) (g/Ha) A: B Observed (*Expected)
C79 50 12.5 4:1 100 100
C80 100 12.5 8:1 100 100
C81 200 12.5 16:1 100 100
C82 400 12.5 32:1 100 100
C83 - 12.5 - 100 -
C84 50 - - 23 -
C85 100 - - 23 -
C86 200 - - 28 -
C87 400 - - 28 -
Table B2.22b Herbicidal activity against ELEIN of a compound of Formula (I) (compound 1.010) as component (A)
10 _ and compuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula)
Composition Component Component Ratio ELEIN
ID no. (A) (g/Ha) (B) (g/Ha) A: B Observed (*Expected)
C88 50 12.5 4:1 98 98
C89 100 12.5 8:1 96 98
C90 200 12.5 16:1 96 98
C91 400 12.5 32:1 93 98
C92 - 12.5 - 90 -
C93 50 - - 80 -
C94 100 - - 83 -
C95 200 - - 78 -
C96 400 - - 75 -
Table B2.22c Herbicidal activity against LOLPE of a compound of Formula (I) (compound 1.010) as component
(A) and compuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula)
Composition Component Component Ratio LOLPE
ID no. (A) (g/Ha) (B) (g/Ha) A: B Observed (*Expected)
C97 50 12.5 4:1 43 18
C98 100 12.5 8:1 63 45
C99 200 12.5 16:1 63 54
C100 400 12.5 32:1 75 50
C101 - 12.5 - 3 -
C102 50 - - 15 -
C103 100 - - 40 -
C104 200 - - 53 -
C105 400 - - 48 -
Table B2.22d Herbicidal activity against ECHCG of a compound of Formula (I) (compound 1.010) as component
Composition ID no. (A) and corr Component (A) (g/Ha) ipuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula) Component Ratio ECHCG (B) (g/Ha) A: B Observed (*Expected)
C106 50 12.5 4:1 93 98
C107 100 12.5 8:1 93 99
C108 200 12.5 16:1 97 99
C109 400 12.5 32:1 93 99
C110 - 12.5 - 73
cm 50 - - 94
C112 100 - - 98 -
0113 200 - - 98
0114 400 - - 98 -
5 Table B2.22e Herbicidal activity against ΑΜΑΡΑ of a compound of Formula (I) (compound 1.010) as component
Composition ID no. (A) and compuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula) Component Component Ratio ΑΜΑΡΑ (A) (g/Ha) (B) (g/Ha) A: B Observed (*Expected)
0115 50 12.5 4:1 92 100
0116 100 12.5 8:1 80 100
0117 200 12.5 16:1 100 100
0118 400 12.5 32:1 100 100
0119 - 12.5 - 100 -
C120 50 - - 60 -
0121 100 - - 88 -
0122 200 - - 100
C123 400 - - 100 -
Table B2.23a Herbicidal activity against IPOHE of a compound of Formula (I) (compound 1.027) as component
10 ___________ Composition ID no. (A) and comopund B2.9 as Component Component (A) (g/Ha) (B) (g/Ha) component (B) Ratio ΑΜΑΡΑ A: B Observed (*Expected)
C124 50 10.0 5:1 100 100
C125 100 10.0 10:1 100 100
C126 200 10.0 20:1 100 100
C127 400 10.0 40:1 100 100
C128 - 10.0 - 100 -
C129 50 - - 15 -
C130 100 - - 15 -
C131 200 - - 15
C132 400 - - 15 -
Table B2.23b Herbicidal activity against ECHCG of a compound of Formula (I) (compound 1.027) as component
Composition ID no. (A) and compuond B2.9 as Component Component (A) (g/Ha) (B) (g/Ha) component (B) (*Expected activity as caclulated by the Colby Formula) Ratio ECHCG A:B Observed (*Expected)
C133 50 10.0 5:1 100 100
C134 100 10.0 10:1 100 100
C135 200 10.0 20:1 100 100
C136 400 10.0 40:1 100 100
C137 - 10.0 - 80 -
C138 50 - - 100 -
C139 100 - - 100 -
C140 200 - - 100 -
C141 400 - - 100 -
Table B2.23c Herbicidal activity against ΑΜΑΡΑ of a compound of Formula (I) (compound 1.027) as component (A) and compuond B2.9 as component (B) (*Expected activity as caclulated by the Colby Formula)
Composition ID no. Component (A) (g/Ha) Component (B) (g/Ha) Ratio A: B ΑΜΑΡΑ Observed (*Expected)
C142 50 10.0 5:1 100 100
C143 100 10.0 10:1 93 100
C144 200 10.0 20:1 100 100
C145 - 10.0 - 100 -
C146 50 - - 83
C147 100 - - 100 -
C148 200 - - 100 -

Claims (13)

1. A composition comprising as component (A) a compound of Formula (I), or an agrochemically acceptable sait or a zwitterionic species thereof,
A
(I), wherein:
heteroaryl selected from the group consisting of:
(R8)p
A-l
(R8)p \ N
N
A-IV
A-VII wherein the jagged line defines the point of attachaient to the remaining part of a compound of Formula (I), p is 0, 1 or 2, and each R8 is independently selected from the group consisting of NH2, methyl, and methoxy;
R1 and R2 are each independently hydrogen or methyl;
Q is (CR1aR2b)m;
m is 0, 1, or 2;
each R1a and R2b are independently selected from the group consisting of hydrogen, hydroxy, methyl, and NH2;
Z is -S(O)2OR10, -C(O)OR10, -C(O)NHS(O)2R12 and -C(O)NHCN;
R10 is hydrogen, methyl, benzyl or phenyl;
and R12 is methyl, -NH2, -N(CH3)2, or-NHCH3;
and, as component (B), at least one herbicide or sait thereof selected from the group consisting of:
B1 a non-selective herbicide selected from the group consisting of glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquat and diquat;
B2 a herbicide that acts through the inhibition of protoporphoryinogen oxidase; and
B3 a herbicide that inhibits photosystem II in photosynthesis.
2. The composition of claim 1, wherein Z is selected from the group consisting of:
-C(O)OH, -C(O)OCH3, -S(O)2OH, -C(O)OCH2C6H5, -C(O)OCeHs, and -C(O)NHS(O)2N(CH3)2.
5 3. The composition of claim 1 or claim 2, wherein A is selected from A-l, A-ll, and A-lll as defined in claim 1.
4.
The composition of claim 1, wherein component (A) is selected from the group of 35 compounds shown in the table below:
Compound No. Structure
1.011 O o 'X x V— O r=z Çj \ 2
1.012 Qp IL .Ni yOH GG YY O CF
1.013 Cip c- ! y O
1.014 1 O // wx Z—Z FA V Z \ / )=2
1.015 X f O 1
1.016 nh2 OL ^νΥΥ<Ύν L 0 Π Il o Fx Yx L>r û F 1 F
5. The composition of any one of claims 1 to 4, wherein component (B) is selected from the group of herbicides consisting of:
5 B1 glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquat and diquat;
B2 a herbicide that acts through the inhibition of protoporphoryinogen oxidase, wherein said herbicide is a diphenyl ether, a thiadiazole, a phenypyrazole, an oxadiazole, an Nphenylphthalimides, a pyrimidinedione, a triazolinone, an oxazolidinedione, flufenpyr ethyl, pyraclonil, profluazol, the compound of formula B2.9
10 B2.9, or the compound of formula B2.10
B2.10; and
B3 a herbicide that inhibits photosystem II in photosynthesis, wherein said herbicide is a pyridazinone, a phenyl carbamate, a uracil, a triazinone, an urea, a triazolinone, a 15 triazine, an amide, a nitrile, a phenyl-pyridazine, or a benzothiadiazinone.
6. The composition of claim 5, wherein component B is selected from the group of herbicides consisting of:
B1 glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquat, diquat;
B2 bifenox, ethoxyfen-ethyl, halosafen, lactofen, acifluorfen-sodium, chlomethoxyfen, fluoroglycofen-ethyl, oxyfluorfen, fomesafen, fluthiacet-methyl, thidazimin, fluazolate, pyraflufen-ethyl, oxadiargyl, oxadiazon, cinidon-ethyl, flumiclorac-pentyl, flumioxazin, benzfendizone, butafenacil, saflufenacil, azafenidin, bencarbazone, carfentrazoneethyl, sulfentrazone, pentoxazone, flufenpyr ethyl, pyraclonil, profluazol, the compound of formula B2.9
B3 chloridazon/pyrazon, desmedipham, desmedipham, bromacil, lenacil, terbacil, tiafenacil, hexazinone, metamitron, metribuzin, fenuron, metobromuron, neburon, chlorobromuron, fluometuron, methabenzthiazuron, siduron, chlorotoluron, isoproturon, metoxuron, tebuthiuron, chloroxuron, isouron, monlinuron, dimefuron, linuron, diuron, ethidimuron, amicarbozone, atrazine, desmetryne, propazine, terbuthylazine, dimethametryn, simetryne, terbutryne, ametryne, prometon, simazine, trietazine, prometryne, terbumeton, pentanochlor, propanil, bromofenoxim, bromoxynil, ioxynil, pyridate, pyridafol, and bentazone.
7. The composition of claim 5, or claim 6, wherein component B is selected from the group of herbicides consisting of:
B1 : glyphosate, glufosinate, hydantocidin, pelargonic acid, paraquat, diquat;
B2: B2(i) saflufenacil, B2(ii) fomesafen, B2(iii) oxyfluorfen, B2(iv) butafenacil, B2(v) carfentrazone-ethyl, B2(vi) pyraflufen-ethyl, B2(vii) sulfentrazone, B2(viii) flumioxazin,
B2(ix) the compound of formula
B2.9
B2(x) the compound of formula B2.10
B2.10;
B3: B3(i) atrazine, B3(ii) ametryn, B3(iii) metribuzin, B3(iv) hexazinone, B3(v) diuron, B3(vi) propanil, B3(vii) prometryn, B3(viii) tiafenacil, and B3(ix) trifludimoxazin.
10
8. The composition of any one ofthe preceding claims, wherein the weight ratio of component (A) to component (B) is from 0.01:1 to 100:1.
9. The composition of any one of the preceding claims wherein the weight ratio of component (A) to component (B) is from 0.025:1 to 20:1.
10. The composition of any one ofthe preceding claims, wherein the weight ratio of component (A) to component (B) is from 1:30 to 16:1.
11. The herbicidal composition of any one ofthe preceding claims additionally comprising an 20 agriculturally acceptable formulation adjuvant.
12. The herbicidal composition of claim 11, further comprising at least one additional pesticide.
13. The herbicidal composition according to claim 12, wherein the additional pesticide is a herbicide
25 or herbicide safener.
14. A method of controlling unwanted plant growth, comprising applying a compound of Formula (I) as defined in any one of claims 1 to 5, and a herbicide selected from groups B1, B2 or B3 as defined in any one of claims 1,5, 6, or 7, to the unwanted plants or to the locus thereof.
15. The method of claim 14, wherein the compounds of Formula (I) and the herbicide selected from groups B1, B2,or B3, are applied in the form of a composition as defined in any one of claims 1 to 12.
OA1202100363 2019-02-15 2020-01-30 Herbicidal compositions. OA20326A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201911006088 2019-02-15
IN201911025822 2019-06-28

Publications (1)

Publication Number Publication Date
OA20326A true OA20326A (en) 2022-05-10

Family

ID=

Similar Documents

Publication Publication Date Title
TWI784038B (en) Herbicidal compounds
CA3128409A1 (en) Herbicidal compositions
US20220095618A1 (en) Herbicidal compositions
CA3129110A1 (en) Herbicidal compositions
EP3923724B1 (en) Herbicidal compositions
EP3923727A1 (en) Pre-harvest desiccation method
WO2020164973A1 (en) Pyridazinium compounds for use in a method of controlling unwanted plant growth
US20220159956A1 (en) Herbicidal compositions
OA20326A (en) Herbicidal compositions.